VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
paper
Cited
Public
Unavailable
- Authors
- Koboldt, Daniel C; Zhang, Qunyuan; Larson, David E; Shen, Dong; McLellan, Michael D; Lin, Ling; Miller, Christopher A; Mardis, Elaine R; Ding, Li; Wilson, Richard K
- Year
- 2012
- Journal
- Genome research
- PMID
- 22300766
- DOI
- 10.1101/gr.129684.111
- PMCID
- PMC3290792
Cancer is a disease driven by genetic variation and mutation. Exome sequencing can be utilized for discovering these variants and mutations across hundreds of tumors. Here we present an analysis tool, VarScan 2, for the detection of somatic mutations and copy number alterations (CNAs) in exome data from tumor-normal pairs. Unlike most current approaches, our algorithm reads data from both samples simultaneously; a heuristic and statistical algorithm detects sequence variants and classifies them by somatic status (germline, somatic, or LOH); while a comparison of normalized read depth delineates relative copy number changes. We apply these methods to the analysis of exome sequence data from 151 high-grade ovarian tumors characterized as part of the Cancer Genome Atlas (TCGA). We validated some 7790 somatic coding mutations, achieving 93% sensitivity and 85% precision for single nucleotide variant (SNV) detection. Exome-based CNA analysis identified 29 large-scale alterations and 619 focal events per tumor on average. As in our previous analysis of these data, we observed frequent amplification of oncogenes (e.g., CCNE1, MYC) and deletion of tumor suppressors (NF1, PTEN, and CDKN2A). We searched for additional recurrent focal CNAs using the correlation matrix diagonal segmentation (CMDS) algorithm, which identified 424 significant events affecting 582 genes. Taken together, our results demonstrate the robust performance of VarScan 2 for somatic mutation and CNA detection and shed new light on the landscape of genetic alterations in ovarian cancer.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Accurate detection of somatic single-nucleotide variants from bulk RNA-seq data using RNA-MosaicHunter. | Huang AY et al. | — | 2026 | → |
| A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma. | Wei S et al. | — | 2026 | → |
| Analysis of discordance between mismatch repair and microsatellite instability testing in endometrial cancer. | Xi Y et al. | — | 2026 | → |
| Analysis of genetic mutation characteristics in 40 Chinese patients with hepatocellular carcinoma. | Xu S et al. | — | 2026 | → |
| Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncology. | Che J et al. | — | 2026 | → |
| Ancestry and somatic profile indicate acral melanoma origin and prognosis. | Basurto-Lozada P et al. | — | 2026 | → |
| An open-source clinical bioinformatics pipeline for real-world NGS implementation: translating genomic variants into actionable treatment strategies in oncology. | Privitera GF et al. | — | 2026 | → |
| Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high-frequency PIK3CA mutations revealed by molecular and immunohistochemical analysis. | Nakamura H et al. | — | 2026 | → |
| A sorghum pangenome reference improves global crop trait discovery. | Morris GP et al. | — | 2026 | → |
| Asymmetric sheath coordination controls flagellar architecture and function in Leptospira spirochete. | Kawamoto A et al. | — | 2026 | → |
| Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial. | Kong T et al. | — | 2026 | → |
| Chemical tools for discriminating single nucleotide variants: from design principles to clinical applications. | Huang D et al. | — | 2026 | → |
| Chromosome-level genome assembly of the photobiont microalga Trebouxia sp. 'A48' from the lichen Xanthoria parietina. | Tagirdzhanova G et al. | — | 2026 | → |
| Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex. | Gillis N et al. | — | 2026 | → |
| Comprehensive mapping of RNA modification dynamics and crosstalk via deep learning and nanopore direct RNA-sequencing. | Dong H et al. | — | 2026 | → |
| Deep Learning Technology in Genomics, Radiotherapy, and Ophthalmology for Precision Medicine. | Pratap A et al. | — | 2026 | → |
| De Novo Heterozygous ZFX Frameshift Variant in a Female With an X-Linked Neurodevelopmental Disorder. | Showpnil IA et al. | — | 2026 | → |
| Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor. | Fleming AM et al. | — | 2026 | → |
| Distinct Molecular and Prognostic Profiles of Left- and Right-Sided Colorectal Cancer Revealed by NGS Analysis: The Role of SMAD4 and SETD2 Mutations. | Zhao W et al. | — | 2026 | → |
| Domestication-related changes at PvMYB26 reduce pod shattering in common bean and shed light on the origins of agriculture in the Americas. | Celebioglu B et al. | — | 2026 | → |
| Effectiveness of key - population COVID - 19 prevention depends on overall community - level control: a correctional facility outbreak study in Guangdong, China. | Lin D et al. | — | 2026 | → |
| Elucidation of the genetic architecture stabilizing the heading time in barley (Hordeum vulgare L.). | Okuma M et al. | — | 2026 | → |
| Endometrial Carcinomas With a Somatically Derived Yolk Sac Tumor Component Share Molecular Similarities to p53-abnormal Endometrial Carcinomas and Germ Cell Tumors. | Li JJX et al. | — | 2026 | → |
| ERBB2 amplification is a late event in the pathogenesis of high-grade endometrial carcinomas with heterogeneous HER2 expression. | Chui MH et al. | — | 2026 | → |
| Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursors. | Gomez F et al. | — | 2026 | → |
| Frequent BRAF V600E and TERT promoter-mutated renal epithelial-predominant Wilms tumours with metanephric features: a distinct subset within the Wilms tumour spectrum? | Xu Y et al. | — | 2026 | → |
| Full spatio-temporal analyses of migration and colonization in evolution-dense 3D mapping of cancer metastases provides new insights. | Chen Q et al. | — | 2026 | → |
| Functional germline variants together with somatic mutations alter the integrity of cancer hallmark regulatory networks. | Dai J et al. | — | 2026 | → |
| Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer. | Poturnajova M et al. | — | 2026 | → |
| Genetic landscape of pediatric acute myeloid leukemia in Taiwan. | Cheng Z et al. | — | 2026 | → |
| Genome-wide association study bridging genomics-phenomics gap in natural plant populations. | Roy S et al. | — | 2026 | → |
| Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders. | Kimura T et al. | — | 2026 | → |
| Genomic landscape of paired primary and peritoneal metastatic lesions in gastric cancer highlights evolutionary dynamics and mutational drivers. | Li S et al. | — | 2026 | → |
| Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse. | Huang CH et al. | — | 2026 | → |
| Homologous recombination deficiency and hemizygosity drive resistance in breast cancer. | Safonov A et al. | — | 2026 | → |
| Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution. | Pepper-Tunick E et al. | — | 2026 | → |
| Immunopeptidomics combined with full-length transcriptomics uncovers diverse neoantigens. | Ishino T et al. | — | 2026 | → |
| Impact of mutations affecting 4'-fluorouridine susceptibility on fitness and treatment outcomes for Venezuelan equine encephalitis virus. | Wong J et al. | — | 2026 | → |
| In-depth Genetic and Molecular Characterization of Unilateral Coexisting Adrenal Cortical Adenoma and Carcinoma in the Context of MEN1 Syndrome. | Cioppi F et al. | — | 2026 | → |
| Integrative genomic analysis identifies clinically relevant prognostic markers for colorectal cancer patients with liver metastasis. | Li W et al. | — | 2026 | → |
| Integrative multi-omics analysis identified FUT9 and MS4A3 as novel immune-phenotype and prognosis biomarkers for colorectal cancer and analyze the role of FUT9 in oncoimmunology. | Zhu M et al. | — | 2026 | → |
| Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML. | Karigane D et al. | — | 2026 | → |
| Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trial. | Zhang W et al. | — | 2026 | → |
| Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areas. | Chamba C et al. | — | 2026 | → |
| Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials. | Tirtei E et al. | — | 2026 | → |
| Matrilineal Genetic Analysis of Tibeto-Burman-Speaking Populations in Guizhou. | Pan S et al. | — | 2026 | → |
| Metastatic progression of pheochromocytoma and paraganglioma occurs via parallel evolution. | Pregnall AM et al. | — | 2026 | → |
| Microglandular adenosis, triple negative breast carcinoma and DNA repair defects. | Bedell M et al. | — | 2026 | → |
| Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC. | Yang Q et al. | — | 2026 | → |
| Molecular origin, discovery, validation and application of neoantigens. | Lyu Q et al. | — | 2026 | → |
| Multi-Omics Profiling Uncovers Predictive Factors for Tumor-Infiltrating Lymphocyte Therapy in Ovarian Cancer. | Wang X et al. | — | 2026 | → |
| Mutational profiles of spontaneous and radiation-related mammary carcinomas in a rat model of Brca1 haploinsufficiency. | Nakamura Y et al. | — | 2026 | → |
| Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors. | Okada M et al. | — | 2026 | → |
| Parallel but distinct adaptive routes in the budding and fission yeasts after 10,000 generations of experimental evolution. | N'Guessan A et al. | — | 2026 | → |
| Phase II trial of neoadjuvant camrelizumab and apatinib in resectable NSCLC: 3-year survival outcomes and dynamic circulating tumor DNA analyses. | Guo W et al. | — | 2026 | → |
| Photorin controls the intracellular activation and bacteriotoxic effect of Photorhabdus laumondii protease S during its expression in Escherichia coli. | Svetlova AO et al. | — | 2026 | → |
| Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression. | Kader T et al. | — | 2026 | → |
| Phylogenomics of Plasmopara halstedii Reveals Genomic Regions Associated With the Breakdown of Sunflower Downy Mildew Resistance Genes. | Pecrix Y et al. | — | 2026 | → |
| Phylogeny-Aware Metabologenomics Accurately Assigns Natural Products to Biosynthetic Gene Clusters. | Boldt J et al. | — | 2026 | → |
| PKC-eta promotes breast cancer metastasis by regulating the Hippo-YAP signaling pathway. | Liju VB et al. | — | 2026 | → |
| Points to consider for the next-generation-sequencing-based detection of copy-number abnormalities (CNAs) and balanced chromosomal rearrangements in neoplastic disorders: A statement of the American College of Medical Genetics and Genomics (ACMG). | Schieffer KM et al. | — | 2026 | → |
| Pollution-Driven Selection in a Non-Biting Midge: Genome-Wide Responses to Bacillus thuringiensis israelensis and Copper. | Röder N et al. | — | 2026 | → |
| Prognostic stratification of chordoid meningiomas: the role of chromosome 1p/22q Loss. | Paterra R et al. | — | 2026 | → |
| PUMA-induced apoptosis drives bone marrow failure and genomic instability in telomerase-deficient mice. | Molnar C et al. | — | 2026 | → |
| The Landscape of CEACAM5 Expression by Immunohistochemistry in NSCLC. | Hsu YR et al. | — | 2026 | → |
| Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18-gene panel. | Spenard E et al. | — | 2026 | → |
| Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer. | Riaz N et al. | — | 2026 | → |
| Tutorial for variant interrogation in tumor samples. | Arseneau RJ et al. | — | 2026 | → |
| Variant calling in genomics: A comparative performance analysis and decision guide. | Pinto V et al. | — | 2026 | → |
| Whole Exome Sequencing of Feline Oral Squamous Cell Carcinoma Reveals Genomic Parallels With Human Head and Neck Squamous Cell Carcinoma. | Chu S et al. | — | 2026 | → |
| Whole genome sequencing data of early- and late-onset colorectal cancer in 99 Korean patients. | Kim JY et al. | — | 2026 | → |
| Aberrant basal cell clonal dynamics shape early lung carcinogenesis. | Gómez-López S et al. | — | 2025 | → |
| A case report and literature review: Diagnosis of pelvic retroperitoneal angiomyofibroblastoma assisted by next-generation sequencing. | Meng Y et al. | — | 2025 | → |
| Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic. | Park J et al. | — | 2025 | → |
| A chimeric viral platform for directed evolution in mammalian cells. | Cole AJ et al. | — | 2025 | → |
| A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations. | Li Y et al. | — | 2025 | → |
| A Comprehensive Bioinformatics Approach to Analysis of Variants: Variant Calling, Annotation, and Prioritization. | Koroglu MN et al. | — | 2025 | → |
| A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy. | Huber F et al. | — | 2025 | → |
| A comprehensive targeted panel of 295 genes: Unveiling key disease initiating and transformative biomarkers in multiple myeloma. | Ruhela V et al. | — | 2025 | → |
| Acquired multiple <i>EGFR</i> mutations‑mediated resistance to a third‑generation tyrosine kinase inhibitor in a patient with lung adenocarcinoma who responded to afatinib: A case report and literature review. | Yang F et al. | — | 2025 | → |
| Adaptive Challenges of Past and Future Invasion of Drosophila suzukii: Insights From Novel Genomic Resources and Statistical Methods Combining Individual and Pool Sequencing Data. | Camus L et al. | — | 2025 | → |
| Advances in bioinformatics and multi-omics integration: transforming viral infectious disease research in veterinary medicine. | Elrashedy A et al. | — | 2025 | → |
| Advancing precision oncology with AI-powered genomic analysis. | Srivastava R | — | 2025 | → |
| Advantages of updated WHO mutation catalog combined with existing whole-genome sequencing-based approaches for Mycobacterium tuberculosis resistance prediction. | Chen Y et al. | — | 2025 | → |
| A multi-task domain-adapted model to predict chemotherapy response from mutations in recurrently altered cancer genes. | Jayagopal A et al. | — | 2025 | → |
| A new member of the novel, non-core Brucella clade: An exotic frog isolate closely related to atypical Brucella isolates from recent human brucellosis cases in Australia. | Ufermann CM et al. | — | 2025 | → |
| A pan-azole and pan-echinocandin resistant Wickerhamomyces anomalus isolate causing bloodstream infection: ERG11<sup>Y140F</sup>, <sup>K151R</sup> with copy number variation and FKS1<sup>F665S</sup> mutation. | Luo Z et al. | — | 2025 | → |
| APOBEC3A drives deaminase mutagenesis in human gastric epithelium. | An Y et al. | — | 2025 | → |
| APOBEC3 mutagenesis drives therapy resistance in breast cancer. | Gupta A et al. | — | 2025 | → |
| A protein-based classifier for differentiating follicular thyroid adenoma and carcinoma. | Sun Y et al. | — | 2025 | → |
| A Rare Noncoding Enhancer Variant in <i>SCN5A</i> Contributes to the High Prevalence of Brugada Syndrome in Thailand. | Walsh R et al. | — | 2025 | → |
| A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription. | Minello A et al. | — | 2025 | → |
| A Splice-Region Variant Causes an Atypical Presentation of GNAS Inactivation Disorder. | Stone BS et al. | — | 2025 | → |
| Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing. | Subramanian DN et al. | — | 2025 | → |
| Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study. | Schönung M et al. | — | 2025 | → |
| A Telomere-to-telomere Diploid Reference Genome and Centromere Structure of the Chinese Quartet. | Wang 王博 B et al. | — | 2025 | → |
| BALF editome profiling reveals A-to-I RNA editing associated with severity and complications of <i>Mycoplasma pneumoniae</i> pneumonia in children. | Jin Y-Y et al. | — | 2025 | → |
| Bioinformatics prediction and experimental verification identify B4GALT1 as a diagnostic biomarker of glioblastoma. | Lu X et al. | — | 2025 | → |
| Brain metastases lung adenocarcinoma patients with BRG1 loss have a grim prognosis, featuring unique morphological and methylation characteristics. | Yang J et al. | — | 2025 | → |
| CaMutQC: An R package for integrative quality control and filtration of cancer somatic mutations. | Wang X et al. | — | 2025 | → |
| Cancer genomics and bioinformatics in Latin American countries: applications, challenges, and perspectives. | Torres-Narvaez ES et al. | — | 2025 | → |
| CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer. | Chia S et al. | — | 2025 | → |
| CanSeer: a translational methodology for developing personalized cancer models and therapeutics. | Butt RN et al. | — | 2025 | → |
| Case Report: Genomic profiling in an invasive solid papillary carcinoma patient with liver metastasis and a history of invasive lobular carcinoma. | Wang X et al. | — | 2025 | → |
| CCRR: a user-friendly platform for analyzing complex chromosomal rearrangements in tumors. | Liu J et al. | — | 2025 | → |
| CDKN2A alternations in non-small cell lung cancer: An evaluation using next-generation sequencing. | Feng X et al. | — | 2025 | → |
| Characterisation of β-tubulin isotypes in Uncinaria stenocephala and implications for benzimidazole resistance in hookworms. | Stocker T et al. | — | 2025 | → |
| Characteristics and filtering of low-frequency artificial short deletion variations based on nanopore sequencing. | Ye F et al. | — | 2025 | → |
| Characterization of clinical risk factors for enhanced molecular residual disease monitoring in resected early-stage non-small cell lung cancer. | Shi Y et al. | — | 2025 | → |
| Characterization of <i>RET</i> fusions via integrated DNA and RNA sequencing in early-stage non-small cell lung cancer: a retrospective study. | Ding Y et al. | — | 2025 | → |
| Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcoma. | Husted C et al. | — | 2025 | → |
| Characterization of Tumor Antigens from Multi-omics Data: Computational Approaches and Resources. | Wang Y et al. | — | 2025 | → |
| Circulating tumor DNA as a marker of molecular residual disease in resected esophageal squamous cell carcinoma. | Fang CY et al. | — | 2025 | → |
| Circulating tumor-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress anti-tumor immunity in patients with melanoma. | Lu BY et al. | — | 2025 | → |
| Clinical characteristics and treatment of EGFR exon 19 L747 mutation in advanced NSCLC: a retrospective study. | Yang Y et al. | — | 2025 | → |
| Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9. | Helderman NC et al. | — | 2025 | → |
| Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women. | Ezzat D et al. | — | 2025 | → |
| Clonal Hematopoiesis Is Associated With Adverse Clinical Outcomes and Left Ventricular Remodeling in Aortic Stenosis. | Yao CY et al. | — | 2025 | → |
| Colorectal Adenoma Subtypes Exhibit Signature Molecular Profiles: Unique Insights into the Microenvironment of Advanced Precancerous Lesions for Early Detection Applications. | Mancuso FM et al. | — | 2025 | → |
| Comparative Genomics of Chloropicon primus and Chloropicon roscoffensis Provide Insights into the Evolutionary Dynamics and Ecological Success of These Tiny Green Algae in Marine Environments. | Turmel M et al. | — | 2025 | → |
| Comparative Transcriptomics Analysis of Foot-and-Mouth Disease Virus-Infected Cell Model Systems. | Ma H et al. | — | 2025 | → |
| CompàreGenome: a command-line tool for genomic diversity estimation in prokaryotes and eukaryotes. | Moro G et al. | — | 2025 | → |
| Complexity of the lichen symbiosis revealed by metagenome and transcriptome analysis of Xanthoria parietina. | Tagirdzhanova G et al. | — | 2025 | → |
| Comprehensive assessment of computational methods for cancer immunoediting. | He S et al. | — | 2025 | → |
| Comprehensive assessment of whole-genome sequencing-based variant calling pipelines in monozygotic twins. | Tan C et al. | — | 2025 | → |
| Comprehensive benchmarking of methods for mutation calling in circulating tumor DNA. | Carrié H et al. | — | 2025 | → |
| Computational and biological modeling of IGF1R inhibition for multifocal medulloblastoma. | Almer AG et al. | — | 2025 | → |
| Computational methods and data resources for predicting tumor neoantigens. | Zhao X et al. | — | 2025 | → |
| Continuous targeted hypermutation with a tunable mutation window. | Lee C et al. | — | 2025 | → |
| CRISPR-Cas9-mediated knockout of OsKCS11 in rice reveals potential crosstalk between very-long-chain fatty acids and cytokinin. | Zhou J et al. | — | 2025 | → |
| C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemia. | Gonzalez Martinez A et al. | — | 2025 | → |
| Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer. | Nørgaard M et al. | — | 2025 | → |
| Defining APOBEC-induced mutation signatures and modifying activities in yeast. | Mertz TM et al. | — | 2025 | → |
| Detection of Chromosomal Aneuploidy Using Exome Sequencing. | Al-Hamed MH et al. | — | 2025 | → |
| Detection of spontaneous anti-neoepitope T-cell responses in non-metastatic bladder cancer patients. | Brochier W et al. | — | 2025 | → |
| Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score. | von Bornemann Fløe L et al. | — | 2025 | → |
| DICER1 in pediatric and adult cancer predisposition populations: Prevalence, phenotypes, and mosaicism. | Salvador L et al. | — | 2025 | → |
| Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinoma. | Huang CY et al. | — | 2025 | → |
| Distinguishing MPLCs from IPMs using NGS-based molecular algorithms and histological assessment: A systematic review and validation study. | Yang D et al. | — | 2025 | → |
| Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer. | Ewing A et al. | — | 2025 | → |
| DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer. | Chislock EM et al. | — | 2025 | → |
| Emergence of novel sublineages of Mycobacterium tuberculosis in Pakistan. | Khan MT et al. | — | 2025 | → |
| Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal models. | Wang X et al. | — | 2025 | → |
| Erysipelothrix in Cook Inlet, Alaska, USA: an emerging bacterial pathogen of the endangered Cook Inlet beluga whale. | Rouse N et al. | — | 2025 | → |
| European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma. | Bolli N et al. | — | 2025 | → |
| Evaluating sensitivity of NGS-based mutation detection across diverse sample types in prostate cancer. | Jiang K et al. | — | 2025 | → |
| Evolutionary unpredictability in cancer model systems. | Chattopadhyay S et al. | — | 2025 | → |
| Extreme heterochiasmy and high rates of sex-reversed recombination result in large yet homomorphic sex chromosomes in the Emei moustache toad. | Xie S et al. | — | 2025 | → |
| Extremely early genomic events and temporal order of esophageal squamous cell carcinogenesis: Longitudinal self-comparison of progressors and non-progressors. | Liu Y et al. | — | 2025 | → |
| FBP1 controls liver cancer evolution from senescent MASH hepatocytes. | Gu L et al. | — | 2025 | → |
| Fragile X messenger ribonucleoprotein 1 (FMRP) regulates glycolytic gene expression under chronic hypoxia in HCT116 cells. | Ogura Y et al. | — | 2025 | → |
| Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma. | Sharma S et al. | — | 2025 | → |
| Genetic alteration of class I HLA in cutaneous T-cell lymphoma. | Kwang AC et al. | — | 2025 | → |
| Genetic analysis of uterine lavage fluids to identify women at high risk of endometrial cancer. | Hrstka R et al. | — | 2025 | → |
| Genetic Sequencing of a Bacterial Pneumonia Vaccine Produced in 1916. | Xiao Y et al. | — | 2025 | → |
| Genome architecture evolution in an invasive copepod species complex. | Du Z et al. | — | 2025 | → |
| Genome-to-genome analysis reveals associations between human and mycobacterial genetic variation in tuberculosis patients from Tanzania. | Xu ZM et al. | — | 2025 | → |
| Genome-wide DNA methylation profiles of colorectal tumors in Lynch syndrome and familial adenomatous polyposis. | Mäki-Nevala S et al. | — | 2025 | → |
| Genome-wide Genetic Mutations Accumulated in Pigs Genome-edited for Xenotransplantation and Their Filial Generation. | Huo 霍学云 X et al. | — | 2025 | → |
| Genomic Analysis of Global Mycobacterium abscessus Isolates Reveals Ongoing Evolution of Drug Resistance-Associated Genes. | Yang T et al. | — | 2025 | → |
| Genomic and DNA methylomic factors associated with the efficacy of oral medroxyprogesterone acetate on endometrial neoplastic disease. | Sugiyama Y et al. | — | 2025 | → |
| Genomic characterization of host gene alterations in Theileria annulata-transformed leukocytes. | Dandasena D et al. | — | 2025 | → |
| Genomic epidemiology and antimicrobial resistance of <i>Corynebacterium macclintockiae</i>, the predominant species of human pathogens within the <i>Corynebacterium jeikeium</i> complex. | Harada S et al. | — | 2025 | → |
| Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 Vaccine. | Basile K et al. | — | 2025 | → |
| Genomic implications of the repeated shift to self-fertilization across a species' geographic distribution. | Lucek K et al. | — | 2025 | → |
| Genomic landscape of a long-term surviving patient with metastatic cancer of the larynx: a case report. | Bišof V et al. | — | 2025 | → |
| Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer. | Chaubal R et al. | — | 2025 | → |
| GENOMICON-Seq enables realistic simulation of amplicon and exome sequencing for low-frequency mutation detection. | Stosic MS et al. | — | 2025 | → |
| Genomic pathogenic alterations in the SWI/SNF complex compromise the outcomes of immunotherapy in Chinese patients with KRAS-mutant NSCLC by downregulating STING expression. | Gao L et al. | — | 2025 | → |
| Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma. | Ouyang Z et al. | — | 2025 | → |
| Genomic surveillance of SARS-CoV-2 variants using pooled WGS. | Park I et al. | — | 2025 | → |
| Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition. | Fiorica PN et al. | — | 2025 | → |
| Germline predisposition in multiple myeloma. | Martins Rodrigues F et al. | — | 2025 | → |
| Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppression. | Blomquist MR et al. | — | 2025 | → |
| GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated <i>EZH2</i> and <i>TP53</i> at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses. | Shahar Gabay T et al. | — | 2025 | → |
| GPNMB Expression Identifies FLCN -Associated Eosinophilic Renal Tumors With Heterogeneous Clinicopathologic Spectrum and Gene Expression Profiles. | Xia QY et al. | — | 2025 | → |
| Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm. | Gharaee N et al. | — | 2025 | → |
| Harnessing novel cytidine deaminases from the animal kingdom for robust multiplexed base editing in rice. | Contiliani DF et al. | — | 2025 | → |
| High Tumor Mutation Burden (TMB) and a Novel Somatic Mutation in the TREX1 Gene in a Patient with Aggressive and Refractory High-Grade B-Cell Lymphoma: A Case Report. | Gusakova M et al. | — | 2025 | → |
| Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence. | Arce-Gallego S et al. | — | 2025 | → |
| Identification and Functional Validation of Novel Pathogenic Variants in Primary Immunodeficiencies. | Vr A et al. | — | 2025 | → |
| Identification and molecular characterization of missense mutations in orphan G protein-coupled receptor GPR61 occurring in severe obesity. | Tsang CH et al. | — | 2025 | → |
| Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape. | Cook AL et al. | — | 2025 | → |
| Identification of regulatory genes associated with POAG by integrating expression and sequencing data. | Wang X et al. | — | 2025 | → |
| Identification of Viral Variants from Functional Genomics Data. | Röckl F et al. | — | 2025 | → |
| Immunohistochemical and molecular evolutionary features of jejunoileal adenocarcinoma unveiled through comparative analysis with colorectal adenocarcinoma. | Ishikawa R et al. | — | 2025 | → |
| Impact of sublineage diversity on intrinsic susceptibility of Beijing genotype Mycobacterium tuberculosis. | Li H et al. | — | 2025 | → |
| Improved identification of tumor-specific TCRs from circulating lymphocytes using autologous colorectal tumor organoids. | Ma L et al. | — | 2025 | → |
| Increased heterozygosity and balancing selection in isofemale generations of Anopheles stephensi under laboratory conditions. | Mohanty AK et al. | — | 2025 | → |
| Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors. | Ma J et al. | — | 2025 | → |
| Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy. | Peng T et al. | — | 2025 | → |
| Induced somatic mutation accumulation during skeletal muscle regeneration reduces muscle strength. | Vrtačnik P et al. | — | 2025 | → |
| Integrated Multiomics Validation of Key <i>MUC</i> Gene Expression for the Signature Biomarker in the Pakistani Cohort. | Naeem M et al. | — | 2025 | → |
| Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma. | Mendeville MS et al. | — | 2025 | → |
| Integrative multi-omics and computer-aided biofungicide design approach to combat fusarium wilt of chickpea. | Sahoo R et al. | — | 2025 | → |
| Integrative proteogenomic characterization of Wilms tumor. | Cheng C et al. | — | 2025 | → |
| Interferon-γ-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia. | Takahashi R et al. | — | 2025 | → |
| Internal migrants as drivers of long-distance cross-regional transmission of tuberculosis in China. | Li M et al. | — | 2025 | → |
| In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity. | Sussman JH et al. | — | 2025 | → |
| Learning the cellular origins across cancers using single-cell chromatin landscapes. | Bairakdar MD et al. | — | 2025 | → |
| LIPID RICH 1 modulates allocation of carbon between starch and triacylglycerol in Arabidopsis leaves. | Yamaguchi M et al. | — | 2025 | → |
| <i>Corynebacterium striatum</i> infections in oncologic patients: clinical spectrum, resistance profiles, and evidence of nosocomial transmission. | Yukawa K et al. | — | 2025 | → |
| <i>PPM1D</i> Mutation as a Distinct Feature of Myeloid Neoplasms in B-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis. | Kim H et al. | — | 2025 | → |
| <i>TP53</i> mutation and immunohistochemical p53 expression characteristics in diffuse large B-cell lymphoma. | Jin Y et al. | — | 2025 | → |
| Lung-directed delivery of a ligand-mediated chimeric lysin has an enhanced ability to eradicate pulmonary and intracellular Staphylococcus aureus. | Zhang X et al. | — | 2025 | → |
| Managing severe dermatitis and grade 4 pneumonitis in a patient with non-small-cell lung cancer following pembrolizumab treatment: A case report. | Wang Y et al. | — | 2025 | → |
| Maternal lineage diversity and health-related haplogroups in the Gilgiti and Kohistani populations of northern Pakistan. | Adnan A et al. | — | 2025 | → |
| Maternal Myo-Inositol Deficiency Involved Autophagy Impairment by PI3K/Akt/mTOR Signaling in Neural Tube Defects During Pregnancy. | Guo J et al. | — | 2025 | → |
| Meropenem-induced cross-protection in Salmonella enterica resistant variants: Insights from adaptive laboratory evolution and whole genome sequencing. | Tavares da Silva R et al. | — | 2025 | → |
| Metagenome-assembled genome of <i>Staphylococcus nepalensis</i> from urban bats in China. | Jiang X et al. | — | 2025 | → |
| MET and NF2 alterations confer primary and early resistance to first-line alectinib treatment in ALK-positive non-small-cell lung cancer. | Hu J et al. | — | 2025 | → |
| Methylglyoxal mutagenizes single-stranded DNA via Rev1-associated slippage and mispairing. | Vijayraghavan S et al. | — | 2025 | → |
| Molecular Characteristics and Treatment Implications of TP53 Gain-of-Function Mutations in Non-Small Cell Lung Cancer. | Zhao Z et al. | — | 2025 | → |
| Molecular Characterization of Oral Squamous Cell Carcinoma in Mexican Patients: A Genomic and Epidemiological Overview. | Lopez-Gomez J et al. | — | 2025 | → |
| Molecular features influencing clinical outcome of advanced HER2-positive gastric cancer receiving trastuzumab plus chemotherapy. | Lei Y et al. | — | 2025 | → |
| Mosaicism and intronic variants in RB1 gene revealed by next generation sequencing in a cohort of Spanish retinoblastoma patients. | Gomez-Mariano G et al. | — | 2025 | → |
| Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome. | Hamada M et al. | — | 2025 | → |
| MOV&RSim: computational modelling of cancer-specific variants and sequencing reads characteristics for realistic tumoral sample simulation. | Longhin F et al. | — | 2025 | → |
| MRD4U: A path to development for personalized liquid biopsy for children with central nervous system tumors. | Miller AR et al. | — | 2025 | → |
| MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous samples. | Wang T et al. | — | 2025 | → |
| mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes. | Ibragimova AA et al. | — | 2025 | → |
| Multimodal integration strategies for clinical application in oncology. | Zhang B et al. | — | 2025 | → |
| Multi-omics insights into the molecular signature and prognosis of hypopharyngeal squamous cell carcinoma. | Ren Y et al. | — | 2025 | → |
| Multiple Chemical Sensitivity and the SLC Gene Superfamily: A Case-Control Study. | Alcorta E et al. | — | 2025 | → |
| Multiple DNA repair pathways prevent acetaldehyde-induced mutagenesis in yeast. | Porcher L et al. | — | 2025 | → |
| Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy. | Rizvi N et al. | — | 2025 | → |
| Mutations adjacent to the nucleotide-binding cleft of Arabidopsis thaliana ACTIN7 confer resistance to the actin-disrupting compound latrunculin B. | Sparks JA et al. | — | 2025 | → |
| Mutations in chikungunya virus nsP4 decrease viral fitness and sensitivity to the broad-spectrum antiviral 4'-Fluorouridine. | Yin P et al. | — | 2025 | → |
| Nanobioreactor detection of space-associated hematopoietic stem and progenitor cell aging. | Pham J et al. | — | 2025 | → |
| Neoadjuvant sintilimab and chemotherapy followed by transoral surgery for HPV-positive resectable oropharyngeal cancer: a single-arm, two-centre, phase 2 trial. | Yan S et al. | — | 2025 | → |
| Neoantigen load as a predictor of relapse in early-stage NSCLC: features that agonise and antagonise prognosis. | Ye L et al. | — | 2025 | → |
| New insights into the genetic progression of cancer through longitudinal analysis of oral lesions. | Wils LJ et al. | — | 2025 | → |
| Next generation DNA sequencing data analysis and its application in clinical genomics. | Beura A et al. | — | 2025 | → |
| Novel antimicrobial 3-phenyl-4-phenoxypyrazole derivatives target cell wall lipid intermediates with low mammalian cytotoxicity. | Fernandez-Ciruelos B et al. | — | 2025 | → |
| Novel Intragenic Duplication of GATAD2B in a Patient With GAND. | Mori M et al. | — | 2025 | → |
| Novel Resistance Mechanisms to Second-Generation EGFR Tyrosine Kinase Inhibitor Afatinib and Associations With Genomic Features in NSCLC. | Lin F et al. | — | 2025 | → |
| Nuclear genome sequencing reveals the highly intron-rich architecture of the chlorarachniophyte alga Amorphochlora amoebiformis. | Aoki D et al. | — | 2025 | → |
| Ongoing evolution of PE/PPE genes in <i>Mycobacterium tuberculosis</i> associated with drug resistance and host immune response. | Gan M et al. | — | 2025 | → |
| Over-expression and increased copy numbers of a cytochrome P450 and two UDP-glucuronosyltransferase genes in macrocyclic lactone resistant Psoroptes ovis of cattle. | Hearn J et al. | — | 2025 | → |
| Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. | Yin X et al. | — | 2025 | → |
| Patient-specific mutation of contact site protein Tomm70 causes neurodegeneration. | Garg V et al. | — | 2025 | → |
| Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies. | Lee HJ et al. | — | 2025 | → |
| Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer. | Roudier MP et al. | — | 2025 | → |
| Patterns of spontaneous and induced genomic alterations in <i>Yarrowia lipolytica</i>. | Xiong Y-R et al. | — | 2025 | → |
| Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses. | Li J et al. | — | 2025 | → |
| Polyploidy-mediated variations in glutamate receptor proteins linked to Fusarium wilt resistance in upland cotton. | Parris S et al. | — | 2025 | → |
| Potential Value of AURKA and CDK6 Amplification for the Response of Patients With Gastric Cancer to Neoadjuvant Chemotherapy. | Tan Y et al. | — | 2025 | → |
| Precision proteogenomics reveals pan-cancer impact of germline variants. | Martins Rodrigues F et al. | — | 2025 | → |
| Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers. | Palomero J et al. | — | 2025 | → |
| Predicting Tumor Antigens Using the LENS Workflow Through RAFT. | Vensko Ii SP et al. | — | 2025 | → |
| Pretreatment circulating tumor DNA and tissue genomic profiling concordance in ovarian cancer: a prospective observational study of influencing factors and clinical implications. | Su H et al. | — | 2025 | → |
| Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers. | Hoskins EL et al. | — | 2025 | → |
| Prevalence and therapeutic response of EGFR T790I mutation in NSCLC patients with acquired resistance to EGFR-TKIs: a retrospective cohort study. | Shi J et al. | — | 2025 | → |
| Prevalence of <i>Rocahepevirus ratti</i> (rat hepatitis E virus) in humans and rats in China. | Cui X et al. | — | 2025 | → |
| Prognosis conferred by molecular features of appendix-derived Pseudomyxoma Peritonei. | Ma R et al. | — | 2025 | → |
| Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups. | Ji S et al. | — | 2025 | → |
| Quantifying Early-Stage Lung Adenocarcinoma Progression with a Radiomic Trajectory. | Qiu ZB et al. | — | 2025 | → |
| Radiation therapy results in preferential tumor antigen-specific lymphodepletion in head and neck cancer. | Zenga J et al. | — | 2025 | → |
| Rapid and dynamic evolution of a giant Y chromosome in <i>Silene latifolia</i>. | Akagi T et al. | — | 2025 | → |
| Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, Singapore. | Su YCF et al. | — | 2025 | → |
| Recurrence Prediction by Multi-Omics in the Patient with Colorectal Peritoneal Metastases After Cytoreductive Surgery: A Prospective Biomarker Study. | Chen C et al. | — | 2025 | → |
| Recurrent spontaneous miscarriages from sperm after ABVD chemotherapy in a patient with Hodgkin's lymphoma: sperm DNA and methylation profiling. | Lecuyer G et al. | — | 2025 | → |
| Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate Cancer. | Rahimirad S et al. | — | 2025 | → |
| Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer. | Petersson A et al. | — | 2025 | → |
| Revealing the potential transmission route of Cnaphalocrocis medinalis granulovirus capable of persistently causing granulosis epidemics. | Chen B et al. | — | 2025 | → |
| RMVar 2.0: an updated database of functional variants in RNA modifications. | Huang Y et al. | — | 2025 | → |
| Role of microbial life history strategy in shaping the characteristics and evolution of host-microbiota interactions. | Obeng N et al. | — | 2025 | → |
| SCANER: robust and sensitive identification of malignant cells from the scRNA-seq profiled tumor ecosystem. | Xia P et al. | — | 2025 | → |
| Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer. | Antonucci L et al. | — | 2025 | → |
| Single cell long-read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-myeloproliferative neoplasm acute myeloid leukemia | Grabek J et al. | — | 2025 | — |
| Sintilimab plus chemotherapy for first-line treatment of advanced pulmonary lymphoepithelioma-like carcinoma: Phase 2 trial. | Lin X et al. | — | 2025 | → |
| Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma. | Sam I et al. | — | 2025 | → |
| Somatic Mutation Profiling and Therapeutic Landscape of Breast Cancer in the MENA Region. | Velayutham D et al. | — | 2025 | → |
| Space-associated stem cell hallmarks of aging and resilience in astronauts. | Pham J et al. | — | 2025 | → |
| Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review). | Feng H et al. | — | 2025 | → |
| Targeted Next-Generation Sequencing of Cell-Free DNA to Detect <i>MYC</i>-Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East Africa. | Chamba C et al. | — | 2025 | → |
| Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer. | Peng Z et al. | — | 2025 | → |
| The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial. | Xu D et al. | — | 2025 | → |
| The evaluation of different combinations of enzyme set, aligner and caller in GBS sequencing of soybean. | Zamalutdinov A et al. | — | 2025 | → |
| The genetic polymorphism of XPR1 associated with Fanconi syndrome in Chinese patients with X-linked hypophosphatemia. | Han S et al. | — | 2025 | → |
| The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia. | Ahlgren L et al. | — | 2025 | → |
| The global genomic landscape of hypervirulent <i>Klebsiella pneumoniae</i> from 1932 to 2021. | Jiang X et al. | — | 2025 | → |
| The landscape of 142 Epstein-Barr viral whole genomes in gastric cancer. | Kojima Y et al. | — | 2025 | → |
| The landscape of cell lineage tracing. | Feng Y et al. | — | 2025 | → |
| The Marchantia polymorpha pangenome reveals ancient mechanisms of plant adaptation to the environment. | Beaulieu C et al. | — | 2025 | → |
| The molecular cartography of malignant and benign sebaceous tumours. | Ferreira I et al. | — | 2025 | → |
| The NEXT complex regulates H3K27me3 levels to affect cancer progression by degrading G4/U-rich lncRNAs. | Yang Q et al. | — | 2025 | → |
| The Oncologist, 2025, Vol, XX, Issue XX Predictive role of ARID1A and B2M mutations and the antigen presentation pathway in the efficacy of definitive chemoradiotherapy for cervical cancer. | Zhu C et al. | — | 2025 | → |
| The roles of NHEJ and TLS pathways in genomic alterations and phenotypic evolution in the yeast Yarrowia lipolytica. | Yan C et al. | — | 2025 | → |
| TMBquant: an explainable AI-powered caller advancing tumor mutation burden quantification across heterogeneous samples. | Wang S et al. | — | 2025 | → |
| Tracking Antimicrobial Resistant Organisms Timely: a workflow validation study for successive core-genome SNP-based nosocomial transmission analysis. | Aoki K et al. | — | 2025 | → |
| Transcriptome Concordance Between Borderline Tumors and Endometrioid Carcinoma: An Integrative Genomic Analysis. | Takahashi M et al. | — | 2025 | → |
| Translation of bi-directional transcripts enhances MHC-I peptide diversity. | Zavadil F et al. | — | 2025 | → |
| Trastuzumab and pertuzumab plus carboplatin-based neoadjuvant therapy for HER2-positive breast cancer: a prospective cohort study with integrated genomic and transcriptomic biomarker analysis. | Qian X et al. | — | 2025 | → |
| UNISOM: Unified Somatic Calling and Machine Learning-based Classification Enhance the Discovery of CHIP. | Tian S et al. | — | 2025 | → |
| Unleashing the Power of Multiomics: Unraveling the Molecular Landscape of Peripheral Neuropathy. | Choi J et al. | — | 2025 | → |
| Utilization of primary tumor samples for cancer neoantigen discovery. | Leko V et al. | — | 2025 | → |
| UVA-induced DNA damage and mutations in human melanocytes: relevance for melanoma mutations. | Jin SG et al. | — | 2025 | → |
| Whole exome sequencing and single-cell DNA sequencing for assessment of clonal heterogeneity and evolution in acute myeloid leukemia. | Adhikari S et al. | — | 2025 | → |
| Whole-exome sequencing of FFPE samples reveals mutations associated with Luminal A breast cancer recurrence. | Lv K et al. | — | 2025 | → |
| Whole-exome sequencing reveals the mutational landscape of head and neck lymphoepithelioma-like carcinoma. | Zhang Q et al. | — | 2025 | → |
| Whole exome sequencing shows novel COL4A3 and COL4A4 variants as causes of Alport syndrome in Rio Grande do Norte, Brazil. | de Araújo WC et al. | — | 2025 | → |
| Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer. | Martín-Arana J et al. | — | 2025 | → |
| Whole-genome and whole-exome sequencing of Mayer-Rokitansky-Küster-Hauser syndrome-discordant monozygotic twins. | Ma W et al. | — | 2025 | → |
| Widespread presence of bone marrow-like hematopoietic stem cell niche in invertebrate skeletons. | Lian S et al. | — | 2025 | → |
| A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing. | Guille A et al. | — | 2024 | → |
| A biomarker exploration in small-cell lung cancer for brain metastases risk and prophylactic cranial irradiation therapy efficacy. | Li L et al. | — | 2024 | → |
| Accelerated somatic mutation calling for whole-genome and whole-exome sequencing data from heterogenous tumor samples. | Ji S et al. | — | 2024 | → |
| [A consistency comparison between next-generation sequencing and the FISH method for gene rearrangement detection in B-cell lymphomas]. | Yan Z et al. | — | 2024 | → |
| A cryptic syngameon within <i>Betula</i> shrubs revealed: Implications for conservation in changing subarctic environments. | Touchette L et al. | — | 2024 | → |
| ADAR-mediated RNA editing regulates PVR immune checkpoint in colorectal cancer. | Qian CJ et al. | — | 2024 | → |
| Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements. | Feinberg J et al. | — | 2024 | → |
| Aerosolization of viable <i>Mycobacterium tuberculosis</i> bacilli by tuberculosis clinic attendees independent of sputum-Xpert Ultra status. | Patterson B et al. | — | 2024 | → |
| A fully sequenced collection of homozygous EMS mutants for forward and reverse genetic screens in Arabidopsis thaliana. | Carrère S et al. | — | 2024 | → |
| A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms. | Pareja F et al. | — | 2024 | → |
| Alicyclobacillus sp. SO9, a novel halophilic acidophilic iron-oxidizing bacterium isolated from a tailings-contaminated beach, and its effect on copper extraction from chalcopyrite in the presence of high chloride concentration. | Huynh D et al. | — | 2024 | → |
| A low-cost dpMIG-seq method for elucidating complex inheritance in polysomic crops: a case study in tetraploid blueberry. | Nagasaka K et al. | — | 2024 | → |
| A molecular epidemiological and transmission analysis of Clostridioides difficile using draft whole-genome sequencing in a single hospital. | Miyazaki T et al. | — | 2024 | → |
| Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation. | Kervarrec T et al. | — | 2024 | → |
| Ancient mitogenomes from Pre-Pottery Neolithic Central Anatolia and the effects of a Late Neolithic bottleneck in sheep (<i>Ovis aries</i>). | Sandoval-Castellanos E et al. | — | 2024 | → |
| Ancient Mycobacterium leprae genome reveals medieval English red squirrels as animal leprosy host. | Urban C et al. | — | 2024 | → |
| A new genomic framework to categorize pediatric acute myeloid leukemia. | Umeda M et al. | — | 2024 | → |
| A Novel Affordable and Reliable Framework for Accurate Detection and Comprehensive Analysis of Somatic Mutations in Cancer. | Atzeni R et al. | — | 2024 | → |
| A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study. | Liu C et al. | — | 2024 | → |
| Antibiotic-resistant <i>Escherichia coli</i> from treated municipal wastewaters and Black-headed Gull nestlings on the recipient river. | Masarikova M et al. | — | 2024 | → |
| A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation. | Jin Y et al. | — | 2024 | → |
| A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. | Hahn AW et al. | — | 2024 | → |
| ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation. | Chan ICC et al. | — | 2024 | → |
| ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of Resistance to Targeted Therapy. | Okada M et al. | — | 2024 | → |
| ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas. | Nguyen V et al. | — | 2024 | → |
| Assessing the de novo assemblers: a metaviromic study of apple and first report of citrus concave gum-associated virus, apple rubbery wood virus 1 and 2 infecting apple in India. | Khan ZA et al. | — | 2024 | → |
| Assessing the genetic risk of nodular melanoma using a candidate gene approach. | Stark MS et al. | — | 2024 | → |
| Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates. | Ajkunic A et al. | — | 2024 | → |
| Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL. | Mijiti M et al. | — | 2024 | → |
| Association of post-operative ctDNA detection with outcomes of patients with early breast cancers. | Cutts R et al. | — | 2024 | → |
| Auxiliary diagnosis of primary bone tumors based on Machine learning model. | Deng S et al. | — | 2024 | → |
| Avanzando Caminos (Leading Pathways): design and procedures of the Hispanic/Latino Cancer Survivorship Study. | Penedo FJ et al. | — | 2024 | → |
| Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup. | Ramamoorthy S et al. | — | 2024 | → |
| Bifidobacterium species serve as key gut microbiome regulators after intervention in gestational diabetes mellitus. | Cui Z et al. | — | 2024 | → |
| Both Nitro Groups Are Essential for High Antitubercular Activity of 3,5-Dinitrobenzylsulfanyl Tetrazoles and 1,3,4-Oxadiazoles through the Deazaflavin-Dependent Nitroreductase Activation Pathway. | Karabanovich G et al. | — | 2024 | → |
| Bulk and single-cell RNA-seq analyses reveal canonical RNA editing associated with microglia homeostasis and its role in sepsis-associated encephalopathy. | Wei ZY et al. | — | 2024 | → |
| Cancer Biomarkers and Precision Oncology: A Review of Recent Trends and Innovations. | AlDoughaim M et al. | — | 2024 | → |
| CapHLA: a comprehensive tool to predict peptide presentation and binding to HLA class I and class II. | Chang Y et al. | — | 2024 | → |
| Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, <i>KEAP1/STK11</i> co-mutated metastatic NSCLC. | Roussot N et al. | — | 2024 | → |
| CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma. | Saba KH et al. | — | 2024 | → |
| Characterisation and mapping of a Globodera pallida resistance derived from the wild potato species Solanum spegazzinii. | Gartner U et al. | — | 2024 | → |
| Circulating tumour DNA detects somatic variants contributing to spatial and temporal intra-tumoural heterogeneity in head and neck squamous cell carcinoma. | Payne KFB et al. | — | 2024 | → |
| Clinical Interest in Exome-Based Analysis of Somatic Mutational Signatures for Non-Small Cell Lung Cancer. | Peroz M et al. | — | 2024 | → |
| Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival. | Li T et al. | — | 2024 | → |
| Clinicopathological Features of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma: Analysis of Twenty-Two Cases. | Zhang XY et al. | — | 2024 | → |
| Clinicopathologic and Molecular Characterization of Xanthomatous Giant Cell Renal Cell Carcinomas: Further Support for a Close Morphologic Spectrum to Eosinophilic Solid and Cystic Renal Cell Carcinomas. | Xu Y et al. | — | 2024 | → |
| Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer Patients. | Parigger T et al. | — | 2024 | → |
| Comparative genome analyses of clinical and non-clinical <i>Clostridioides difficile</i> strains. | Schüler MA et al. | — | 2024 | → |
| Comprehensive Analysis of Microsatellite Instability in Canine Cancers: Implications for Comparative Oncology and Personalized Veterinary Medicine. | Mazzone E et al. | — | 2024 | → |
| Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors. | Kuehn JC et al. | — | 2024 | → |
| Comprehensive genomic characterization of hematologic malignancies at a pediatric tertiary care center. | Kebede AM et al. | — | 2024 | → |
| CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction. | Grigoriadis K et al. | — | 2024 | → |
| Construction of an immune-related gene prognostic model for obese endometrial cancer patients based on bioinformatics analysis. | Tong Y et al. | — | 2024 | → |
| Contributing factors to the oxidation-induced mutational landscape in human cells. | Cordero C et al. | — | 2024 | → |
| Convergent epigenetic evolution drives relapse in acute myeloid leukemia. | Nuno K et al. | — | 2024 | → |
| Converging and evolving immuno-genomic routes toward immune escape in breast cancer. | Blanco-Heredia J et al. | — | 2024 | → |
| Copy number signatures and CCNE1 amplification reveal the involvement of replication stress in high-grade endometrial tumors oncogenesis. | Marlin R et al. | — | 2024 | → |
| Copy number variation heterogeneity reveals biological inconsistency in hierarchical cancer classifications. | Yang Z et al. | — | 2024 | → |
| Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional study. | Huang Z et al. | — | 2024 | → |
| COSAP: Comparative Sequencing Analysis Platform. | Ergun MA et al. | — | 2024 | → |
| Deconstructing Intratumoral Heterogeneity through Multiomic and Multiscale Analysis of Serial Sections. | Schupp PG et al. | — | 2024 | → |
| DEEPOMICS FFPE, a deep neural network model, identifies DNA sequencing artifacts from formalin fixed paraffin embedded tissue with high accuracy. | Heo DH et al. | — | 2024 | → |
| Demography-driven and adaptive introgression in a hybrid zone of the Armeria syngameon. | Villa-Machío I et al. | — | 2024 | → |
| De novo detection of somatic mutations in high-throughput single-cell profiling data sets. | Muyas F et al. | — | 2024 | → |
| Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities. | Lozac'hmeur A et al. | — | 2024 | → |
| Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in <i>Mycobacterium</i> abscessus. | Phelps GA et al. | — | 2024 | → |
| Differences in oxazolidinone resistance mechanisms and small colony variants emergence of <i>Staphylococcus aureus</i> induced in an <i>in vitro</i> resistance development model. | Staudacher M et al. | — | 2024 | → |
| Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. | Iglesia MD et al. | — | 2024 | → |
| Differential somatic coding variant landscapes between laser microdissected luminal epithelial cells from canine mammary invasive ductal solid carcinoma and comedocarcinoma. | Deckwirth V et al. | — | 2024 | → |
| Discover Mutational Differences Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma and Search for More Effective Biomarkers for Immunotherapy. | Nu Er Lan STE et al. | — | 2024 | → |
| Discovery and Biosynthesis of Persiathiacins: Unusual Polyglycosylated Thiopeptides Active Against Multidrug Resistant Tuberculosis. | Dashti Y et al. | — | 2024 | → |
| Dissecting the invasion history of Spotted-Wing Drosophila (Drosophila suzukii) in Portugal using genomic data. | Sario S et al. | — | 2024 | → |
| DNA cytosine methylation suppresses meiotic recombination at the sex-determining region. | Ge T et al. | — | 2024 | → |
| Dynamic A-to-I RNA editing during acute neuroinflammation in sepsis-associated encephalopathy. | Li YN et al. | — | 2024 | → |
| Dysregulated RNA editing of EIF2AK2 in polycystic ovary syndrome: clinical relevance and functional implications. | Kong FS et al. | — | 2024 | → |
| EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome. | Kato S et al. | — | 2024 | → |
| ECOLE: Learning to call copy number variants on whole exome sequencing data. | Mandiracioglu B et al. | — | 2024 | → |
| Effects of temozolomide on tumor mutation burden and microsatellite instability in melanoma cells. | Sawada M et al. | — | 2024 | → |
| Empirical Bayes single nucleotide variant-calling for next-generation sequencing data. | Karimnezhad A et al. | — | 2024 | → |
| Enrichment of oligodendrocyte precursor phenotypes in subsets of low-grade glioneuronal tumours. | Duan Z et al. | — | 2024 | → |
| Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia. | Mulet-Lazaro R et al. | — | 2024 | → |
| Evaluating Bioinformatics Processing of Somatic Variant Detection in cfDNA Using Targeted Sequencing with UMIs. | Lin Y et al. | — | 2024 | → |
| Evaluation of AAICare®-TB sequence analysis tool for accurate diagnosis of drug-resistant tuberculosis: A comparative study with TB-Profiler and Mykrobe. | Singhal R et al. | — | 2024 | → |
| Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA. | Kutz O et al. | — | 2024 | → |
| Exploring Genetic Diversity of SOD2 and POU5F1 for Congenital Heart Disease in the Southwest Chinese Population. | Jin Y et al. | — | 2024 | → |
| Exploring genetic diversity, population structure, and subgenome differences in the allopolyploid <i>Camelina sativa</i>: implications for future breeding and research studies. | Brock JR et al. | — | 2024 | → |
| Fast and accurate variant identification tool for sequencing-based studies. | Gaston JM et al. | — | 2024 | → |
| Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients. | Kreins AY et al. | — | 2024 | → |
| Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. | Hutchcraft ML et al. | — | 2024 | → |
| Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers. | Acanda De La Rocha AM et al. | — | 2024 | → |
| Females translate male mRNA transferred during mating. | Matzkin LM et al. | — | 2024 | → |
| FLI1 is associated with regulation of DNA methylation and megakaryocytic differentiation in FPDMM caused by a RUNX1 transactivation domain mutation. | Tanaka Y et al. | — | 2024 | → |
| Gene signatures of endoplasmic reticulum stress and mitophagy for prognostic risk prediction in lung adenocarcinoma. | Lin X et al. | — | 2024 | → |
| Gene-specific somatic epigenetic mosaicism of FDFT1 underlies a non-hereditary localized form of porokeratosis. | Saito S et al. | — | 2024 | → |
| Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma. | Gotoh O et al. | — | 2024 | → |
| Genetic architecture of disease resistance and tolerance in Douglas-fir trees. | Singh P et al. | — | 2024 | → |
| Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan. | Hida T et al. | — | 2024 | → |
| Genetic characterization and fine mapping of a recessive genic male-sterile gene in flowering Chinese cabbage (<i>Brassica rapa var. parachinensis</i>). | Wu Z et al. | — | 2024 | → |
| Genetic interactions reveal distinct biological and therapeutic implications in breast cancer. | Lin CJ et al. | — | 2024 | → |
| Genetic variants in androgenetic alopecia: insights from scalp RNA sequencing data. | Premanand A et al. | — | 2024 | → |
| Genetic variation across and within individuals. | Yu Z et al. | — | 2024 | → |
| Genome resources for three modern cotton lines guide future breeding efforts. | Sreedasyam A et al. | — | 2024 | → |
| Genomic Alterations Correlated to Trastuzumab Resistance and Clinical Outcomes in HER2+/HR- Breast Cancers of Patients Living in Northwestern China. | Ma G et al. | — | 2024 | → |
| Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma. | Linder A et al. | — | 2024 | → |
| Genomic analysis of an aggressive hepatic leiomyosarcoma case following treatment for hepatocellular carcinoma. | Numata Y et al. | — | 2024 | → |
| Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations. | Dopeso H et al. | — | 2024 | → |
| Genomic characteristics and genetic manipulation of the marine yeast Scheffersomyces spartinae. | Sharma A et al. | — | 2024 | → |
| Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. | Wils LJ et al. | — | 2024 | → |
| Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma. | Kazandjian D et al. | — | 2024 | → |
| Germline susceptibility from broad genomic profiling of pediatric brain cancers. | Mardis ER et al. | — | 2024 | → |
| G-Quadruplex Forming DNA Sequence Context Is Enriched around Points of Somatic Mutations in a Subset of Multiple Myeloma Patients. | Zhuk AS et al. | — | 2024 | → |
| Hallmarks of a genomically distinct subclass of head and neck cancer. | Muijlwijk T et al. | — | 2024 | → |
| HerpesDRG: a comprehensive resource for human herpesvirus antiviral drug resistance genotyping. | Charles OJ et al. | — | 2024 | → |
| High-grade Solid Pseudopapillary Neoplasms of the Pancreas: Distinct Clinicopathological Malignant Features With Intriguing Gene Alterations through a Comparison With the Conventional Type. | Honda S et al. | — | 2024 | → |
| High performance TadA-8e derived cytosine and dual base editors with undetectable off-target effects in plants. | Fan T et al. | — | 2024 | → |
| Hippocampal adenosine-to-inosine RNA editing in sepsis: dynamic changes and influencing factors. | Jin YY et al. | — | 2024 | → |
| Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors. | Moreno-Moreno E et al. | — | 2024 | → |
| How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody. | Marcink TC et al. | — | 2024 | → |
| Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. | Köhnke T et al. | — | 2024 | → |
| Human cytomegalovirus harnesses host L1 retrotransposon for efficient replication. | Hwang SY et al. | — | 2024 | → |
| Human parainfluenza virus 3 field strains undergo extracellular fusion protein cleavage to activate entry. | Stearns K et al. | — | 2024 | → |
| Identification of hypoxia-related gene signatures based on multi-omics analysis in lung adenocarcinoma. | Luo Q et al. | — | 2024 | → |
| Identification of osteoporosis genes using family studies. | Schembri M et al. | — | 2024 | → |
| Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing. | Yu Z et al. | — | 2024 | → |
| <i>Erysipelothrix amsterdamensis</i> sp. nov., associated with mortalities among endangered seabirds. | Zhong J et al. | — | 2024 | → |
| <i>KMT2A</i> Mutations and High Prevalence of dMMR-associated Mutational Signatures as Prognostic Indicators in Metastatic Colorectal Cancer. | Han Z et al. | — | 2024 | → |
| Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence. | Manuto L et al. | — | 2024 | → |
| Impaired neutrophil-mediated cell death drives Ewing's Sarcoma in the background of Down syndrome. | Peirone S et al. | — | 2024 | → |
| Inside <i>Mycobacterium bovis</i> SB0120 spoligotype circulating in Italy: analysis of the most frequent genotypes by whole genome sequencing. | Scaltriti E et al. | — | 2024 | → |
| Insight into mammary gland development and tumor progression in an E2F5 conditional knockout mouse model. | To B et al. | — | 2024 | → |
| Integrated approach to generate artificial samples with low tumor fraction for somatic variant calling benchmarking. | Sergi A et al. | — | 2024 | → |
| Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy. | Gronauer R et al. | — | 2024 | → |
| Integrated molecular and functional characterization of the intrinsic apoptotic machinery identifies therapeutic vulnerabilities in glioma. | Fernandez EG et al. | — | 2024 | → |
| Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks. | Qu N et al. | — | 2024 | → |
| Integrated proteogenomic characterization of glioblastoma evolution. | Kim KH et al. | — | 2024 | → |
| Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients. | Das D et al. | — | 2024 | → |
| IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes. | Qiu Z et al. | — | 2024 | → |
| <i>TP53</i>-specific mutations serve as a potential biomarker for homologous recombination deficiency in breast cancer: a clinical next-generation sequencing study. | Huang Y et al. | — | 2024 | → |
| Kuura-An automated workflow for analyzing WES and WGS data. | Jambulingam D et al. | — | 2024 | → |
| labelSeg: segment annotation for tumor copy number alteration profiles. | Zhao H et al. | — | 2024 | → |
| Landscape of Concomitant Driver Alterations in Classical <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer. | Wang H et al. | — | 2024 | → |
| Leveraging new methods for comprehensive characterization of mitochondrial DNA in esophageal squamous cell carcinoma. | Zhuang X et al. | — | 2024 | → |
| Long-read genome sequencing resolves complex genomic rearrangements in rare genetic syndromes. | Showpnil IA et al. | — | 2024 | → |
| <i>Hydra</i> has mammal-like mutation rates facilitating fast adaptation despite its nonaging phenotype. | Sahm A et al. | — | 2024 | → |
| <i>Vibrio cholerae</i> O1 experiences mild bottlenecks through the gastrointestinal tract in some but not all cholera patients. | Lypaczewski P et al. | — | 2024 | → |
| Metagenomic and paleopathological analyses of a historic documented collection explore ancient dental calculus as a diagnostic tool. | Austin RM et al. | — | 2024 | → |
| MetaQuad: shared informative variants discovery in metagenomic samples. | Xu S et al. | — | 2024 | → |
| Mitochondrial DNA mosaicism in normal human somatic cells. | An J et al. | — | 2024 | → |
| MitoSort: Robust Demultiplexing of Pooled Single-cell Genomic Data Using Endogenous Mitochondrial Variants. | Tang Z et al. | — | 2024 | → |
| Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling. | Hobor S et al. | — | 2024 | → |
| Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study. | Tang J et al. | — | 2024 | → |
| Molecular characterization and biomarker identification in paediatric B-cell acute lymphoblastic leukaemia. | Du Y et al. | — | 2024 | → |
| Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examined. | Shatara M et al. | — | 2024 | → |
| Molecular evolution of intestinal-type early gastric cancer according to Correa cascade. | Li F et al. | — | 2024 | → |
| Molecular pathology as basis for timely cancer diagnosis and therapy. | Mackinnon AC et al. | — | 2024 | → |
| Molecular patterns of resistance to immune checkpoint blockade in melanoma. | Lauss M et al. | — | 2024 | → |
| Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma. | Chao A et al. | — | 2024 | → |
| Morphometric analysis of nuclear shape irregularity as a novel predictor of programmed death-ligand 1 expression in lung squamous cell carcinoma. | Saito-Koyama R et al. | — | 2024 | → |
| Mugen-UMAP: UMAP visualization and clustering of mutated genes in single-cell DNA sequencing data. | Li T et al. | — | 2024 | → |
| Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. | Dinić J et al. | — | 2024 | → |
| Multi-omics analysis unveils immunosuppressive microenvironment in the occurrence and development of multiple pulmonary lung cancers. | Zhang J et al. | — | 2024 | → |
| Multi-scale signaling and tumor evolution in high-grade gliomas. | Liu J et al. | — | 2024 | → |
| Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT. | Bernabéu-Herrero ME et al. | — | 2024 | → |
| Neoantigen identification: Technological advances and challenges. | Pu T et al. | — | 2024 | → |
| Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma. | Huang Y et al. | — | 2024 | → |
| Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial. | Larkin J et al. | — | 2024 | → |
| Nutritional niches of potentially endemic, facultatively anaerobic heterotrophs from an isolated Antarctic terrestrial hydrothermal refugium elucidated through metagenomics. | Herbold CW et al. | — | 2024 | → |
| Ocular A-to-I RNA editing signatures associated with SARS-CoV-2 infection. | Jin YY et al. | — | 2024 | → |
| Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer. | Boilève A et al. | — | 2024 | → |
| Origin of biogeographically distinct ecotypes during laboratory evolution. | Valenzuela JJ et al. | — | 2024 | → |
| Outbreak of <i>Streptococcus pyogenes emm89</i> ST646 in a head and neck surgical oncology ward. | Hayama B et al. | — | 2024 | → |
| Patient-derived organoids and mini-PDX for predicting MET<sup>N375S</sup>-mutated lung cancer patient clinical therapeutic response. | Jiang M et al. | — | 2024 | → |
| Personalized therapy guided by longitudinal liquid biopsies for treatment of leptomeningeal disease from lung adenocarcinoma: A case report. | Lai M et al. | — | 2024 | → |
| Phage-driven coevolution reveals trade-off between antibiotic and phage resistance in <i>Salmonella anatum</i>. | Zhao Y et al. | — | 2024 | → |
| PHDtools: A platform for pathogen detection and multi-dimensional genetic signatures decoding to realize pathogen genomics data analyses online. | Xiong D et al. | — | 2024 | → |
| Phylogenomics of Brachystegia: Insights into the origin of African miombo woodlands. | Boom AF et al. | — | 2024 | → |
| PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL. | Lahera A et al. | — | 2024 | → |
| Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA. | Chen C et al. | — | 2024 | → |
| Plasmid-mediated acquisition and chromosomal integration of <i>bla</i><sub>CTX-M-14</sub> in a subclade of <i>Escherichia coli</i> ST131-<i>H</i>30 clade C1. | Komori K et al. | — | 2024 | → |
| Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma. | Pelster MS et al. | — | 2024 | → |
| Preclinical efficacy and safety of encapsulated proliferating human hepatocyte organoids in treating liver failure. | Yuan X et al. | — | 2024 | → |
| Predominant transmission of KPC-2 carbapenemase in Germany by a unique IncN plasmid variant harboring a novel non-transposable element (NTE <i><sub>KPC</sub></i> -Y). | Yao Y et al. | — | 2024 | → |
| Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation. | Elhassan YS et al. | — | 2024 | → |
| Profiling of RNA editing events in plant organellar transcriptomes with high-throughput sequencing. | Liu K et al. | — | 2024 | → |
| PySNV for complex intra-host variation detection. | Li L et al. | — | 2024 | → |
| Quantitative and qualitative mutational impact of ionizing radiation on normal cells. | Youk J et al. | — | 2024 | → |
| Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer. | Ramakrishnan S et al. | — | 2024 | → |
| radioGWAS links radiome to genome to discover driver genes with somatic mutations for heterogeneous tumor image phenotype in pancreatic cancer. | Zheng D et al. | — | 2024 | → |
| Rare-variant and polygenic analyses of amyotrophic lateral sclerosis in the French-Canadian genome. | Ross JP et al. | — | 2024 | → |
| RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade. | Nokin MJ et al. | — | 2024 | → |
| Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1. | Ozawa T et al. | — | 2024 | → |
| Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLC. | Li L et al. | — | 2024 | → |
| Redefining the treponemal history through pre-Columbian genomes from Brazil. | Majander K et al. | — | 2024 | → |
| Relics of interspecific hybridization retained in the genome of a drought-adapted peanut cultivar. | Grabowski PP et al. | — | 2024 | → |
| Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. | Hynds RE et al. | — | 2024 | → |
| Resolving tumor evolution: a phylogenetic approach. | Li L et al. | — | 2024 | → |
| Revising pathogenesis of AP1S1-related MEDNIK syndrome: a missense variant in the AP1S1 gene as a causal genetic lesion. | Rackova M et al. | — | 2024 | → |
| RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity. | Jin YY et al. | — | 2024 | → |
| rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC. | Polcaro G et al. | — | 2024 | → |
| Rumicidins are a family of mammalian host-defense peptides plugging the 70S ribosome exit tunnel. | Panteleev PV et al. | — | 2024 | → |
| Sensitivity of Plasmopara viticola to selected fungicide groups and the occurrence of the G143A mutant in Australian grapevine isolates. | Ismail I et al. | — | 2024 | → |
| Sentinel Surveillance reveals phylogenetic diversity and detection of linear plasmids harboring <i>vanA</i> and <i>optrA</i> among enterococci collected in the United States. | Kent AG et al. | — | 2024 | → |
| Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell-redirecting therapy. | Duell J et al. | — | 2024 | → |
| Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer. | Huang A et al. | — | 2024 | → |
| Single-cell lineage tracing with endogenous markers. | Xue Y et al. | — | 2024 | → |
| Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study. | Huang Y et al. | — | 2024 | → |
| Somatic Tumor Testing in Prostate Cancer: Experience of a Tertiary Care Center Including Pathologist-Driven Reflex Testing of Localized Tumors at Diagnosis. | Prendeville S et al. | — | 2024 | → |
| STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia. | Fischer A et al. | — | 2024 | → |
| The aryl hydrocarbon receptor differentially modulates the expression profile of antibody isotypes in a human B-cell line. | Bhakta-Yadav MS et al. | — | 2024 | → |
| The Bioinformatic Applications of Hi-C and Linked Reads. | Jiang L et al. | — | 2024 | → |
| The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification. | Fanelli A et al. | — | 2024 | → |
| The performance of homopolymer detection using dichromatic and tetrachromatic fluorogenic next-generation sequencing platforms. | Chen H et al. | — | 2024 | → |
| The Post-transplant Lymphoproliferative Disorders-Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods and Protocol. | Dharnidharka VR et al. | — | 2024 | → |
| The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | Caswell DR et al. | — | 2024 | → |
| The T cell receptor β chain repertoire of tumor infiltrating lymphocytes improves neoantigen prediction and prioritization. | Pham TMQ et al. | — | 2024 | → |
| The tissue and circulating cell-free DNA-derived genetic landscape of premalignant colorectal lesions and its application for early diagnosis of colorectal cancer. | Chen Q et al. | — | 2024 | → |
| The Transcriptional Program of <i>Staphylococcus aureus</i> Phage K Is Affected by a Host <i>rpoC</i> Mutation That Confers Phage K Resistance. | Kongari R et al. | — | 2024 | → |
| TMBcalc: a computational pipeline for identifying pan-cancer Tumor Mutational Burden gene signatures. | Privitera GF et al. | — | 2024 | → |
| Toripalimab plus anlotinib in patients with recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm phase 2 trial (TORAL). | Zhang Y et al. | — | 2024 | → |
| Tracing ALS Degeneration: Insights from Spinal Cord and Cortex Transcriptomes. | Sneha NP et al. | — | 2024 | → |
| Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade Response. | Guo YA et al. | — | 2024 | → |
| Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma. | Zacharias NM et al. | — | 2024 | → |
| Transformers meets neoantigen detection: a systematic literature review. | Machaca V et al. | — | 2024 | → |
| Translational Approach to Social Isolation During a Global Pandemic: Hippocampal Somatic Mutation and Stress. | Lee B et al. | — | 2024 | → |
| Transmission of global clones of NDM-producing Enterobacterales and interspecies spread of IncX3 plasmid harbouring bla<sub>NDM-5</sub> in Tokyo. | Harada S et al. | — | 2024 | → |
| Treatment resistance to melanoma therapeutics on a single cell level. | Yao L et al. | — | 2024 | → |
| Trends of Drug-Resistant Tuberculosis in an Urban and a Rural Area in China: A 10-Year Population-Based Molecular Epidemiological Study. | Xu P et al. | — | 2024 | → |
| Tumour evolution and microenvironment interactions in 2D and 3D space. | Mo CK et al. | — | 2024 | → |
| Two complete 1918 influenza A/H1N1 pandemic virus genomes characterized by next-generation sequencing using RNA isolated from formalin-fixed, paraffin-embedded autopsy lung tissue samples along with evidence of secondary bacterial co-infection. | Xiao Y et al. | — | 2024 | → |
| Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopy. | Hotz JF et al. | — | 2024 | → |
| What role do biocontrol agents with Mg<sup>2+</sup> play in the fate of antibiotic resistome and pathogenic bacteria in the phyllosphere? | Zhi Q et al. | — | 2024 | → |
| Whole-genome sequences reveal zygotic composition in chimeric twins. | Yoon CJ et al. | — | 2024 | → |
| Widespread mutagenesis and chromosomal instability shape somatic genomes in systemic sclerosis. | Vijayraghavan S et al. | — | 2024 | → |
| Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis. | Weinstock JS et al. | — | 2023 | → |
| A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children. | Friedrich UA et al. | — | 2023 | → |
| A comparison of algorithms for identifying copy number variants in family-based whole-exome sequencing data and its implications in inheritance pattern analysis. | Ye B et al. | — | 2023 | → |
| A Computational Pipeline for Predicting Cancer Neoepitopes. | Schaap-Johansen AL et al. | — | 2023 | → |
| Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype. | Hiltbrunner S et al. | — | 2023 | → |
| ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA. | Huebner A et al. | — | 2023 | → |
| A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility. | Guo J et al. | — | 2023 | → |
| Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches. | Huang R et al. | — | 2023 | → |
| Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis. | Kim R et al. | — | 2023 | → |
| Advances of mRNA vaccine in tumor: a maze of opportunities and challenges. | Yuan Y et al. | — | 2023 | → |
| A framework for individualized splice-switching oligonucleotide therapy. | Kim J et al. | — | 2023 | → |
| AIVariant: a deep learning-based somatic variant detector for highly contaminated tumor samples. | Jeon H et al. | — | 2023 | → |
| A library of base editors for the precise ablation of all protein-coding genes in the mouse mitochondrial genome. | Silva-Pinheiro P et al. | — | 2023 | → |
| A metabologenomics approach to unlock the metabolome of the novel Antarctic deep-sea isolate <i>Lacinutrix shetlandiensis</i> sp. nov. WUR7. | Vitale GA et al. | — | 2023 | → |
| Analysis of Genetic Ancestry from NGS Data Using EthSEQ. | Dalfovo D et al. | — | 2023 | → |
| Analysis of genome instability and implications for the consequent phenotype in <i>Plasmodium falciparum</i> containing mutated MSH2-1 (P513T). | Honma H et al. | — | 2023 | → |
| An atypical NLR gene confers bacterial wilt susceptibility in Arabidopsis. | Demirjian C et al. | — | 2023 | → |
| An improved reference genome for <i>Trifolium subterraneum</i> L. provides insight into molecular diversity and intra-specific phylogeny. | Shirasawa K et al. | — | 2023 | → |
| A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study). | Ang YLE et al. | — | 2023 | → |
| A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer. | Nguyen VP et al. | — | 2023 | → |
| Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma. | Vasudev NS et al. | — | 2023 | → |
| Application of machine learning to explore the genomic prediction accuracy of fall dormancy in autotetraploid alfalfa. | Zhang F et al. | — | 2023 | → |
| A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets. | Vlasschaert C et al. | — | 2023 | → |
| A predicted CRISPR-mediated symbiosis between uncultivated archaea. | Esser SP et al. | — | 2023 | → |
| A proteogenomics data-driven knowledge base of human cancer. | Liao Y et al. | — | 2023 | → |
| ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors. | Mainwaring OJ et al. | — | 2023 | → |
| A robust microsatellite instability detection model for unpaired colorectal cancer tissue samples. | Zhang Z et al. | — | 2023 | → |
| Arsenic is a potent co-mutagen of ultraviolet light. | Speer RM et al. | — | 2023 | → |
| Association analysis of production traits of Japanese quail (Coturnix japonica) using restriction-site associated DNA sequencing. | Haqani MI et al. | — | 2023 | → |
| A ten long noncoding RNA-based prognostic risk model construction and mechanism study in the basal-like immune-suppressed subtype of triple-negative breast cancer. | Huang X et al. | — | 2023 | → |
| A three‑way complex translocation of (15;15;17)(q24;q14;q21) involving two breakpoints on chromosome 15 in acute promyelocytic leukemia: A case report. | Kim DH | — | 2023 | → |
| A unified DNA- and RNA-based NGS strategy for the analysis of multiple types of variants at the dual nucleic acid level in solid tumors. | Chen H et al. | — | 2023 | → |
| Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibility. | Talwar JV et al. | — | 2023 | → |
| Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania. | Zwyer M et al. | — | 2023 | → |
| Bacterial c-di-GMP has a key role in establishing host-microbe symbiosis. | Obeng N et al. | — | 2023 | → |
| Barcoded multiple displacement amplification for high coverage sequencing in spatial genomics. | Kim J et al. | — | 2023 | → |
| BDL-SP: A Bio-inspired DL model for the identification of altered Signaling Pathways in Multiple Myeloma using WES data. | Ruhela V et al. | — | 2023 | → |
| Beyond rational-biosensor-guided isolation of 100 independently evolved bacterial strain variants and comparative analysis of their genomes. | Baumann PT et al. | — | 2023 | → |
| Brain tropism acquisition: The spatial dynamics and evolution of a measles virus collective infectious unit that drove lethal subacute sclerosing panencephalitis. | Yousaf I et al. | — | 2023 | → |
| Bursts in biosynthetic gene cluster transcription are accompanied by surges of natural compound production in the myxobacterium Sorangium sp. | Boldt J et al. | — | 2023 | → |
| CanISO: a database of genomic and transcriptomic variations in domestic dog (Canis lupus familiaris). | Yang IS et al. | — | 2023 | → |
| Cassava begomovirus species diversity changes during plant vegetative cycles. | Dye AE et al. | — | 2023 | → |
| CCLHunter: An efficient toolkit for cancer cell line authentication. | Bu C et al. | — | 2023 | → |
| CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden. | van den Bulk J et al. | — | 2023 | → |
| CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Wang J et al. | — | 2023 | → |
| CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. | Minami JK et al. | — | 2023 | → |
| Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer. | Christensen E et al. | — | 2023 | → |
| Cell-intrinsic melanin fails to protect melanocytes from ultraviolet-mutagenesis in the absence of epidermal melanin. | Weiss TJ et al. | — | 2023 | → |
| Challenges in neoantigen-directed therapeutics. | Lybaert L et al. | — | 2023 | → |
| Characterization of circRNAs in established osimertinib‑resistant non‑small cell lung cancer cell lines. | Chen X et al. | — | 2023 | → |
| Characterization of the genomic alterations in poorly differentiated thyroid cancer. | Lee Y et al. | — | 2023 | → |
| Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities. | Ganly I et al. | — | 2023 | → |
| Chromosomal Position of Ribosomal Protein Genes Affects Long-Term Evolution of Vibrio cholerae. | Larotonda L et al. | — | 2023 | → |
| Chronic obstructive pulmonary disease alters the genetic landscape and tumor immune microenvironment in lung cancer patients. | Zhang Q et al. | — | 2023 | → |
| Cisplatin exposure alters tRNA-derived small RNAs but does not affect epimutations in C. elegans. | Fallet M et al. | — | 2023 | → |
| Client Applications and Server-Side Docker for Management of RNASeq and/or VariantSeq Workflows and Pipelines of the GPRO Suite. | Hafez AI et al. | — | 2023 | → |
| Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma. | Valero C et al. | — | 2023 | → |
| Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy. | Li L et al. | — | 2023 | → |
| Clinical predominance of whole-exome sequencing to evaluate microsatellite instability status. | Takamatsu R et al. | — | 2023 | → |
| Clinical, Virological, and Immunological Features in Cosmopolitan Genotype DENV-2-Infected Patients during a Large Dengue Outbreak in Sri Lanka in 2017. | Nwe KM et al. | — | 2023 | → |
| Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination-deficient hepatocellular carcinoma. | An J et al. | — | 2023 | → |
| Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity? | Yu J et al. | — | 2023 | → |
| Cloud-native distributed genomic pileup operations. | Wiewiórka M et al. | — | 2023 | → |
| Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma. | Feng J et al. | — | 2023 | → |
| Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma. | Wu Y et al. | — | 2023 | → |
| Comparative chloroplast genome analysis of seven extant Citrullus species insight into genetic variation, phylogenetic relationships, and selective pressure. | Zhou C et al. | — | 2023 | → |
| Comparison and Characterization of Phenotypic and Genomic Mutations Induced by a Carbon-Ion Beam and Gamma-ray Irradiation in Soybean (<i>Glycine max</i> (L.) Merr.). | Feng Z et al. | — | 2023 | → |
| Comprehensive and realistic simulation of tumour genomic sequencing data. | O'Sullivan B et al. | — | 2023 | → |
| Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer. | Lapin M et al. | — | 2023 | → |
| Concomitant <i>PIK3CA</i> and <i>TP53</i> Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis. | Lin XY et al. | — | 2023 | → |
| Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue. | Leenanitikul J et al. | — | 2023 | → |
| Contribution of Spontaneous Mutations to Quantitative and Molecular Variation at the Highly Repetitive rDNA Locus in Yeast. | Sharp NP et al. | — | 2023 | → |
| Control-independent mosaic single nucleotide variant detection with DeepMosaic. | Yang X et al. | — | 2023 | → |
| CRISPR-GRANT: a cross-platform graphical analysis tool for high-throughput CRISPR-based genome editing evaluation. | Fu H et al. | — | 2023 | → |
| Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery. | Zhang B et al. | — | 2023 | → |
| Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma. | Ju G et al. | — | 2023 | → |
| DddA homolog search and engineering expand sequence compatibility of mitochondrial base editing. | Mi L et al. | — | 2023 | → |
| Deciphering the Tangible Spatio-Temporal Spread of a 25-Year Tuberculosis Outbreak Boosted by Social Determinants. | López MG et al. | — | 2023 | → |
| Decreased echinocandin susceptibility in <i>Candida parapsilosis</i> causing candidemia and emergence of a pan-echinocandin resistant case in China. | Ning Y et al. | — | 2023 | → |
| Deep learning predicts the impact of regulatory variants on cell-type-specific enhancers in the brain. | Zheng A et al. | — | 2023 | → |
| Designing neoantigen cancer vaccines, trials, and outcomes. | Biswas N et al. | — | 2023 | → |
| Detection of Cancer-Associated Gene Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South Africa. | Temilola DO et al. | — | 2023 | → |
| Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering. | Okada M et al. | — | 2023 | → |
| Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer. | Liu L et al. | — | 2023 | → |
| Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC. | He P et al. | — | 2023 | → |
| Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma. | Sarver AL et al. | — | 2023 | → |
| Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report. | Singhal K et al. | — | 2023 | → |
| Dual chemical labeling enables nucleotide-resolution mapping of DNA abasic sites and common alkylation damage in human mitochondrial DNA. | Liu C et al. | — | 2023 | → |
| Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation. | Wils LJ et al. | — | 2023 | → |
| Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer. | Freshour SL et al. | — | 2023 | → |
| Engineering of cytosine base editors with DNA damage minimization and editing scope diversification. | Yuan B et al. | — | 2023 | → |
| Epigenetic regulation during cancer transitions across 11 tumour types. | Terekhanova NV et al. | — | 2023 | → |
| Epitranscriptomic investigation of myopia-associated RNA editing in the retina. | Pan XB et al. | — | 2023 | → |
| Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer <i>in vitro</i> models including the rare pleomorphic subentity. | Andus I et al. | — | 2023 | → |
| Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies. | Liu L et al. | — | 2023 | → |
| Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens. | Yamanaka S et al. | — | 2023 | → |
| Evidence for virus-mediated oncogenesis in bladder cancers arising in solid organ transplant recipients. | Starrett GJ et al. | — | 2023 | → |
| Evolution of the viral genomes of SARS-CoV-2 in association with the changes in local condition: a genomic epidemiological study of a suburban city of Japan. | Kashima Y et al. | — | 2023 | → |
| Extension of the Segatella copri complex to 13 species with distinct large extrachromosomal elements and associations with host conditions. | Blanco-Míguez A et al. | — | 2023 | → |
| Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing. | Gray HJ et al. | — | 2023 | → |
| Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning. | McLaughlin RT et al. | — | 2023 | → |
| Fine mapping and candidate gene analysis of a major QTL for oil content in the seed of Brassica napus. | Zhao Q et al. | — | 2023 | → |
| First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutations. | Wang X et al. | — | 2023 | → |
| First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial. | Thibaudin M et al. | — | 2023 | → |
| Fluoroquinolone Residues in the Environment Rapidly Induce Heritable Fluoroquinolone Resistance in <i>Escherichia coli</i>. | Liang H et al. | — | 2023 | → |
| Gene editing in the nematode parasite <i>Nippostrongylus brasiliensis</i> using extracellular vesicles to deliver active Cas9/guide RNA complexes. | Hagen J et al. | — | 2023 | → |
| Genetic alterations of GI-NECs involving three main signaling pathways. | Dai Q et al. | — | 2023 | → |
| Genetic basis of lineage-specific evolution of fruit traits in hexaploid persimmon. | Horiuchi A et al. | — | 2023 | → |
| Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival. | Kotnik EN et al. | — | 2023 | → |
| Genetic evidence for the interaction between <i>Bacillus anthracis</i>-encoded phage receptors and their cognate phage-encoded receptor binding proteins. | Forrest S et al. | — | 2023 | → |
| Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine. | Xiao Y et al. | — | 2023 | → |
| Genome- and transcriptome-wide off-target analyses of a high-efficiency adenine base editor in tomato. | Sretenovic S et al. | — | 2023 | → |
| Genome sequencing reveals the genetic architecture of heterostyly and domestication history of common buckwheat. | Fawcett JA et al. | — | 2023 | → |
| Genome-wide data reveal cryptic diversity and hybridization in a group of tree ferns. | Yi H et al. | — | 2023 | → |
| Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer. | Zhou R et al. | — | 2023 | → |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. | Adamson AW et al. | — | 2023 | → |
| Genomic analysis of two phlebotomine sand fly vectors of Leishmania from the New and Old World. | Labbé F et al. | — | 2023 | → |
| Genomic architecture of autism spectrum disorder in Qatar: The BARAKA-Qatar Study. | Abdi M et al. | — | 2023 | → |
| Genomic characterization of a unique Panton-Valentine leucocidin-positive community-associated methicillin-resistant <i>Staphylococcus aureus</i> lineage increasingly impacting on Australian indigenous communities. | Ramsay JP et al. | — | 2023 | → |
| Genomic comparison of two strains of Mycobacterium avium subsp. paratuberculosis with contrasting pathogenic phenotype. | Colombatti Olivieri MA et al. | — | 2023 | → |
| Genomic epidemiology of <i>Neisseria gonorrhoeae</i> in Shenzhen, China, during 2019-2020: increased spread of ceftriaxone-resistant isolates brings insights for strengthening public health responses. | Wang D et al. | — | 2023 | → |
| Genomic Evidence for Direct Transmission of <i>mecC</i>-MRSA between a Horse and Its Veterinarian. | Albert E et al. | — | 2023 | → |
| Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis. | Johnson TA et al. | — | 2023 | → |
| Genomic Insights into Bacterial Resistance to Proline-Rich Antimicrobial Peptide Bac7. | Panteleev PV et al. | — | 2023 | → |
| Genomic landscape of multiple Bowen's disease using whole-exome sequencing. | Kim YS et al. | — | 2023 | → |
| Genomic landscape of TP53-mutated myeloid malignancies. | Abel HJ et al. | — | 2023 | → |
| Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets. | Vergara IA et al. | — | 2023 | → |
| Genomics of the "tumorigenes" clade of the family Rhizobiaceae and description of Rhizobium rhododendri sp. nov. | Kuzmanović N et al. | — | 2023 | → |
| Genotypic and spatial analysis of transmission dynamics of tuberculosis in Shanghai, China: a 10-year prospective population-based surveillance study. | Li M et al. | — | 2023 | → |
| High-efficiency prime editing enables new strategies for broad-spectrum resistance to bacterial blight of rice. | Gupta A et al. | — | 2023 | → |
| High prevalence of colistin heteroresistance in specific species and lineages of Enterobacter cloacae complex derived from human clinical specimens. | Fukuzawa S et al. | — | 2023 | → |
| Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. | Li Y et al. | — | 2023 | → |
| Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma. | He L et al. | — | 2023 | → |
| Host A-to-I RNA editing signatures in intracellular bacterial and single-strand RNA viral infections. | Wei ZY et al. | — | 2023 | → |
| How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling. | Beeler JS et al. | — | 2023 | → |
| <i>BRCA1</i>-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. | Velazquez C et al. | — | 2023 | → |
| <i>CHEK2</i> Alterations in Pediatric Malignancy: A Single-Institution Experience. | Abdelghani E et al. | — | 2023 | → |
| Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma. | Wei K et al. | — | 2023 | → |
| Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma. | Estabrooks T et al. | — | 2023 | → |
| Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer. | Sun D et al. | — | 2023 | → |
| Identification of neoantigens in oesophageal adenocarcinoma. | Nicholas B et al. | — | 2023 | → |
| Identifying predictive biomarkers of apatinib in third-line treatment of advanced colorectal cancer through comprehensive genomic profiling. | Yang D et al. | — | 2023 | → |
| Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice. | Isidro-Hernández M et al. | — | 2023 | → |
| Immunometabolic coevolution defines unique microenvironmental niches in ccRCC. | Tang C et al. | — | 2023 | → |
| Immunotherapies targeting neoantigens are effective in PD-1 blockade-resistant tumors. | Sun C et al. | — | 2023 | → |
| Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer. | Cartry J et al. | — | 2023 | → |
| Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling. | Nguyen BQT et al. | — | 2023 | → |
| Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation. | Tague LK et al. | — | 2023 | → |
| In Silico Pipeline to Identify Tumor-Specific Antigens for Cancer Immunotherapy Using Exome Sequencing Data. | Morazán-Fernández D et al. | — | 2023 | → |
| Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer. | Cotto KC et al. | — | 2023 | → |
| Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. | Xu L et al. | — | 2023 | → |
| Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer. | Cararo Lopes E et al. | — | 2023 | → |
| Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures. | Hu LS et al. | — | 2023 | → |
| Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancer. | Zhu Y et al. | — | 2023 | → |
| Integrated variant allele frequency analysis pipeline and R package: easyVAF. | Hu J et al. | — | 2023 | → |
| Integrating de novo QTL-seq and linkage mapping to identify quantitative trait loci conditioning physiological resistance and avoidance to white mold disease in dry bean. | Roy J et al. | — | 2023 | → |
| Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue. | Ma S et al. | — | 2023 | → |
| Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA. | Bae M et al. | — | 2023 | → |
| Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. | Liang WW et al. | — | 2023 | → |
| Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity. | Broeker CD et al. | — | 2023 | → |
| Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions. | Bertolini I et al. | — | 2023 | → |
| Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer. | Perelli L et al. | — | 2023 | → |
| Introgressive hybridization in the west Pacific pen shells (genus Atrina): Restricted interspecies gene flow within the genome. | Sekino M et al. | — | 2023 | → |
| Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer--A retrospective study of ctDNA. | Zhang X et al. | — | 2023 | → |
| KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming. | Inagaki T et al. | — | 2023 | → |
| Lack of methoxy-mycolates characterizes the geographically restricted lineage 7 of <i>Mycobacterium tuberculosis</i> complex. | Hailu E et al. | — | 2023 | → |
| Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation. | Jin J et al. | — | 2023 | → |
| Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts. | Reissig TM et al. | — | 2023 | → |
| LDSSNV: A Linkage Disequilibrium-Based Method for the Detection of Somatic Single-Nucleotide Variants. | Lan J et al. | — | 2023 | → |
| Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology. | London CA et al. | — | 2023 | → |
| Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation. | Pagliuca S et al. | — | 2023 | → |
| Lineage tracing for multiple lung cancer by spatiotemporal heterogeneity using a multi-omics analysis method integrating genomic, transcriptomic, and immune-related features. | Song Y et al. | — | 2023 | → |
| Longitudinal Analyses of Mutational Subclonal Architecture and Tumor Subtypes in Recurrent Bladder Cancer. | Ryu D et al. | — | 2023 | → |
| Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models. | da Costa MEM et al. | — | 2023 | → |
| Loss of a Premature Stop Codon in the Rice Wall-Associated Kinase 91 (<i>WAK91</i>) Gene Is a Candidate for Improving Leaf Sheath Blight Disease Resistance. | Al-Bader N et al. | — | 2023 | → |
| Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. | Li X et al. | — | 2023 | → |
| Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction. | Müller M et al. | — | 2023 | → |
| Melanoma in a patient with DNMT3A overgrowth syndrome. | Chen DY et al. | — | 2023 | → |
| Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation. | Gonzalez-Bosquet J et al. | — | 2023 | → |
| Mitochondrial DNA Deficiency and Supplementation in <i>Sus scrofa</i> Oocytes Influence Transcriptome Profiles in Oocytes and Blastocysts. | Okada T et al. | — | 2023 | → |
| Mitochondrial DNA Supplementation of Oocytes Has Downstream Effects on the Transcriptional Profiles of <i>Sus scrofa</i> Adult Tissues with High mtDNA Copy Number. | Okada T et al. | — | 2023 | → |
| Mitochondrial DNA Variants at Low-Level Heteroplasmy and Decreased Copy Numbers in Chronic Kidney Disease (CKD) Tissues with Kidney Cancer. | Kanazashi Y et al. | — | 2023 | → |
| Molecular characterization of <i>Arcobacter butzleri</i> isolates from poultry in rural Ghana. | Zautner AE et al. | — | 2023 | → |
| Molecular characterization of MET fusions from a large real-world Chinese population: A multicenter study. | Xia H et al. | — | 2023 | → |
| Molecular Characterization of Multifocal Granular Cell Tumors. | Dehner CA et al. | — | 2023 | → |
| Molecular landscape of immune pressure and escape in aplastic anemia. | Pagliuca S et al. | — | 2023 | → |
| Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis. | Bui NQ et al. | — | 2023 | → |
| Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma. | Li S et al. | — | 2023 | → |
| Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients. | Al Saati A et al. | — | 2023 | → |
| Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3' untranslated region mutations. | Schuster SL et al. | — | 2023 | → |
| Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome. | Subasri V et al. | — | 2023 | → |
| Mutations in epigenetic regulator <i>KMT2C</i> detected by liquid biopsy are associated with worse survival in prostate cancer patients. | Zhu S et al. | — | 2023 | → |
| Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer. | Li S et al. | — | 2023 | → |
| Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapy. | Puig-Saus C et al. | — | 2023 | → |
| Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort. | Itamochi M et al. | — | 2023 | → |
| New insights into phenotype and genotype relationships in <i>Neospora caninum</i>. | Cabrera A et al. | — | 2023 | → |
| New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol. | Meng FH et al. | — | 2023 | → |
| Newly discovered genomic mutation patterns in radiation-induced small intestinal tumors of ApcMin/+ mice. | Iizuka D et al. | — | 2023 | → |
| Newly identified variability of the antigen binding site coding sequences of the equine major histocompatibility complex class I and class II genes. | Plasil M et al. | — | 2023 | → |
| Next-generation sequencing improves precision medicine in hearing loss. | Imizcoz T et al. | — | 2023 | → |
| Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. | Vos JL et al. | — | 2023 | → |
| Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors. | Schrank TP et al. | — | 2023 | → |
| Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA-A study protocol. | Runkel A et al. | — | 2023 | → |
| Nonlethal Furfural Exposure Causes Genomic Alterations and Adaptability Evolution in Saccharomyces cerevisiae. | Qi L et al. | — | 2023 | → |
| Non-viral precision T cell receptor replacement for personalized cell therapy. | Foy SP et al. | — | 2023 | → |
| Notch Mutations as a Novel Biomarker for Immunotherapy. | Zhou F et al. | — | 2023 | → |
| Novel and reported compensatory mutations in <i>rpoABC</i> genes found in drug resistant tuberculosis outbreaks. | Conkle-Gutierrez D et al. | — | 2023 | → |
| Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential. | Frolova SG et al. | — | 2023 | → |
| NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift. | Richardson ET et al. | — | 2023 | → |
| Nuclear DNA segments homologous to mitochondrial DNA are obstacles for detecting heteroplasmy in sugar beet (Beta vulgaris L.). | Taniguchi E et al. | — | 2023 | → |
| On- and Off-Target Analyses of CRISPR-Cas12b Genome Editing Systems in Rice. | Gurel F et al. | — | 2023 | → |
| Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data. | Roder AE et al. | — | 2023 | → |
| Oral metagenomes from Native American Ancestors reveal distinct microbial lineages in the pre-contact era. | Honap TP et al. | — | 2023 | → |
| Origin and spread of leprosy in Suriname. A historical and biomedical study. | Faber WR et al. | — | 2023 | → |
| Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition. | Abdulla HD et al. | — | 2023 | → |
| Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. | Geffen Y et al. | — | 2023 | → |
| Pan-cancer proteogenomics connects oncogenic drivers to functional states. | Li Y et al. | — | 2023 | → |
| Parallel tuning of semi-dwarfism via differential splicing of Brachytic1 in commercial maize and smallholder sorghum. | Jiao S et al. | — | 2023 | → |
| Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management. | McGee RB et al. | — | 2023 | → |
| PD-L1 expression-related PI3K pathway correlates with immunotherapy efficacy in gastric cancer. | Liu L et al. | — | 2023 | → |
| Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: a prospective diagnostic study: A prospective diagnostic study. | Yuan Z et al. | — | 2023 | → |
| Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer. | Hung SI et al. | — | 2023 | → |
| Phage-resistant mutations impact bacteria susceptibility to future phage infections and antibiotic response. | McGee LW et al. | — | 2023 | → |
| Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer. | Zhao S et al. | — | 2023 | → |
| Phylogenetic and functional analysis of tiller angle control homeologs in allotetraploid cotton. | Kangben F et al. | — | 2023 | → |
| Plasmid-mediated colistin resistance among human clinical <i>Enterobacterales</i> isolates: national surveillance in the Czech Republic. | Zelendova M et al. | — | 2023 | → |
| Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer. | Wang ZZ et al. | — | 2023 | → |
| Post-zygotic rescue of meiotic errors causes brain mosaicism and focal epilepsy. | Miller KE et al. | — | 2023 | → |
| Precise characterization of somatic complex structural variations from tumor/control paired long-read sequencing data with nanomonsv. | Shiraishi Y et al. | — | 2023 | → |
| Primary intracranial sarcomas: a clinicopathological investigation. | Cai YX et al. | — | 2023 | → |
| Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma. | Campbell KM et al. | — | 2023 | → |
| Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field. | Dey R et al. | — | 2023 | → |
| Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy. | Li Z et al. | — | 2023 | → |
| Proteogenomic insights suggest druggable pathways in endometrial carcinoma. | Dou Y et al. | — | 2023 | → |
| Proteogenomics in Cancer: Then and Now. | Wang XY et al. | — | 2023 | → |
| Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ. | Yao Z et al. | — | 2023 | → |
| Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. | Wang Y et al. | — | 2023 | → |
| Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma. | Shen Y et al. | — | 2023 | → |
| Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. | Su GH et al. | — | 2023 | → |
| Rapid Assessment of SARS-CoV-2 Variant-Associated Mutations in Wastewater Using Real-Time RT-PCR. | Farkas K et al. | — | 2023 | → |
| RBFOX2 recognizes N<sup>6</sup>-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. | Dou X et al. | — | 2023 | → |
| Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview. | Seillier L et al. | — | 2023 | → |
| Reference genome of the nutrition-rich orphan crop chia (<i>Salvia hispanica</i>) and its implications for future breeding. | Gupta P et al. | — | 2023 | → |
| Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer. | Yuan SQ et al. | — | 2023 | → |
| Reversion of a resistance-breaking mutation shows reversion costs and high virus diversity at necrotic local lesions. | Moreno-Pérez MG et al. | — | 2023 | → |
| RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification. | Yang Y et al. | — | 2023 | → |
| Role of identified proteins in the proteome profiles of CDK4/6 inhibitor-resistant breast cancer cell lines. | Kumar B et al. | — | 2023 | → |
| Role of succinyl substituents in the mannose-capping of lipoarabinomannan and control of inflammation in Mycobacterium tuberculosis infection. | Palčeková Z et al. | — | 2023 | → |
| SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes. | Fong W et al. | — | 2023 | → |
| Sequence Alignment/Map format: a comprehensive review of approaches and applications. | Liu Y et al. | — | 2023 | → |
| Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy. | Karolová J et al. | — | 2023 | → |
| Sex chromosome heteromorphism and the Fast-X effect in poeciliids. | Darolti I et al. | — | 2023 | → |
| Shuffling the yeast genome using CRISPR/Cas9-generated DSBs that target the transposable Ty1 elements. | Qi L et al. | — | 2023 | → |
| Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma. | Yao L et al. | — | 2023 | → |
| Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer. | Zhao S et al. | — | 2023 | → |
| Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome. | Flerlage T et al. | — | 2023 | → |
| Single nucleotide variants in <i>Pseudomonas aeruginosa</i> populations from sputum correlate with baseline lung function and predict disease progression in individuals with cystic fibrosis. | Saber MM et al. | — | 2023 | → |
| SLAMseq resolves the kinetics of maternal and zygotic gene expression during early zebrafish embryogenesis. | Bhat P et al. | — | 2023 | → |
| Slc9a6 mutation causes Purkinje cell loss and ataxia in the shaker rat. | Figueroa KP et al. | — | 2023 | → |
| Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer. | Burdett NL et al. | — | 2023 | → |
| Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma. | Chen KJ et al. | — | 2023 | → |
| Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives. | Aluri J et al. | — | 2023 | → |
| Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression. | Huang KK et al. | — | 2023 | → |
| Strains Colonizing Different Intestinal Sites within an Individual Are Derived from a Single Founder Population. | Dubinsky V et al. | — | 2023 | → |
| Structurally Complex Osteosarcoma Genomes Exhibit Limited Heterogeneity within Individual Tumors and across Evolutionary Time. | Rajan S et al. | — | 2023 | → |
| Subnanometer structure of an enveloped virus fusion complex on viral surface reveals new entry mechanisms. | Marcink TC et al. | — | 2023 | → |
| Synthase-selected sorting approach identifies a beta-lactone synthase in a nudibranch symbiotic bacterium. | Džunková M et al. | — | 2023 | → |
| Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients. | Ma S et al. | — | 2023 | → |
| Systematic comparison of variant calling pipelines of target genome sequencing cross multiple next-generation sequencers. | Feng B et al. | — | 2023 | → |
| Targeted sequencing of cancer-related genes reveals a recurrent TOP2A variant which affects DNA binding and coincides with global transcriptional changes in glioblastoma. | Gielniewski B et al. | — | 2023 | → |
| T cell receptor and B cell receptor exhibit unique signatures in tumor and adjacent non-tumor tissues of hepatocellular carcinoma. | Xie S et al. | — | 2023 | → |
| Technological and computational approaches to detect somatic mosaicism in epilepsy. | Boßelmann CM et al. | — | 2023 | → |
| Temporal dynamics of SARS-CoV-2 genome mutations that occurred <i>in vivo</i> on an aircraft. | He Y et al. | — | 2023 | → |
| The DNA integrity number and concentration are useful parameters for successful comprehensive genomic profiling test for cancer using formalin-fixed paraffin embedded tissue. | Yanagita E et al. | — | 2023 | → |
| The epigenetic modifier lysine methyltransferase 2C is frequently mutated in gastric remnant carcinoma. | Sun B et al. | — | 2023 | → |
| The evolution of lung cancer and impact of subclonal selection in TRACERx. | Frankell AM et al. | — | 2023 | → |
| The Global Success of Mycobacterium tuberculosis Modern Beijing Family Is Driven by a Few Recently Emerged Strains. | Zhu C et al. | — | 2023 | → |
| The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation. | Li S et al. | — | 2023 | → |
| The Largest Chinese Cohort Study Indicates Homologous Recombination Pathway Gene Mutations as Another Major Genetic Risk Factor for Colorectal Cancer with Heterogeneous Clinical Phenotypes. | Xu Y et al. | — | 2023 | → |
| The MGF300-2R protein of African swine fever virus is associated with viral pathogenicity by promoting the autophagic degradation of IKKα and IKKβ through the recruitment of TOLLIP. | Wang T et al. | — | 2023 | → |
| The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms. | Liu M et al. | — | 2023 | → |
| The OSUMMER lines: A series of ultraviolet-accelerated NRAS-mutant mouse melanoma cell lines syngeneic to C57BL/6. | Murphy BM et al. | — | 2023 | → |
| The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot. | Loiseau C et al. | — | 2023 | → |
| Tislelizumab plus chemotherapy for patients with <i>EGFR</i>-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy. | Zhong H et al. | — | 2023 | → |
| Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing. | Cui S et al. | — | 2023 | → |
| Transcriptome analysis identification of A-to-I RNA editing in granulosa cells associated with PCOS. | Kong FS et al. | — | 2023 | → |
| Transition of allele-specific DNA hydroxymethylation at regulatory loci is associated with phenotypic variation in monozygotic twins discordant for psychiatric disorders. | Ye J et al. | — | 2023 | → |
| TriTrypDB: An integrated functional genomics resource for kinetoplastida. | Shanmugasundram A et al. | — | 2023 | → |
| Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma. | Duan J et al. | — | 2023 | → |
| Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA. | Yang L et al. | — | 2023 | → |
| Uridine-cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine. | Xu Z et al. | — | 2023 | → |
| Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions. | DeZern AE et al. | — | 2023 | → |
| Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy. | Shah RK et al. | — | 2023 | → |
| Validation of genetic variants from NGS data using deep convolutional neural networks. | Vaisband M et al. | — | 2023 | → |
| VirusRecom: an information-theory-based method for recombination detection of viral lineages and its application on SARS-CoV-2. | Zhou ZJ et al. | — | 2023 | → |
| Vision transformer-based weakly supervised histopathological image analysis of primary brain tumors. | Li Z et al. | — | 2023 | → |
| Whole exome and transcriptome analysis revealed the activation of ERK and Akt signaling pathway in canine histiocytic sarcoma. | Asada H et al. | — | 2023 | → |
| Whole-exome sequence analysis of anthropometric traits illustrates challenges in identifying effects of rare genetic variants. | Young KL et al. | — | 2023 | → |
| Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy. | Tanaka T et al. | — | 2023 | → |
| Whole-genome sequencing analysis of molecular epidemiology and silent transmissions causing meticillin-resistant Staphylococcus aureus bloodstream infections in a university hospital. | Sato T et al. | — | 2023 | → |
| Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin. | Lyu T et al. | — | 2023 | → |
| Whole genomes of deep-sea sponge-associated bacteria exhibit high novel natural product potential. | Hesketh-Best PJ et al. | — | 2023 | → |
| Whole mitochondrial and chloroplast genome sequencing of Tunisian date palm cultivars: diversity and evolutionary relationships. | Hamza H et al. | — | 2023 | → |
| Widespread somatic L1 retrotransposition in normal colorectal epithelium. | Nam CH et al. | — | 2023 | → |
| Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues. | Abelin JG et al. | — | 2023 | → |
| Accuracy of genomic selection for alfalfa biomass yield in two full-sib populations. | He X et al. | — | 2022 | → |
| Advantages and Limitations of Monitoring Circulating Tumor DNA Levels to Predict the Prognosis of Patients Diagnosed With Gastric Cancer. | He W et al. | — | 2022 | → |
| A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. | Wang H et al. | — | 2022 | → |
| A G358S mutation in the Plasmodium falciparum Na<sup>+</sup> pump PfATP4 confers clinically-relevant resistance to cipargamin. | Qiu D et al. | — | 2022 | → |
| A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions. | Shin TH et al. | — | 2022 | → |
| Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. | Shah JB et al. | — | 2022 | → |
| A recurrent somatic missense mutation in GNAS gene identified in familial thyroid follicular cell carcinomas in German longhaired pointer dogs. | Yu Y et al. | — | 2022 | → |
| Case report and review of the literature: immune dysregulation in a large familial cohort due to a novel pathogenic RELA variant. | Lecerf K et al. | — | 2022 | → |
| Chloroplast genome assemblies and comparative analyses of commercially important Vaccinium berry crops. | Fahrenkrog AM et al. | — | 2022 | → |
| City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants. | Brunner FS et al. | — | 2022 | → |
| Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer. | Silveira C et al. | — | 2022 | → |
| Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia. | Rosenberg MW et al. | — | 2022 | → |
| Concordance of Genomic Profiles in Matched Tissue and Plasma Samples From Chinese Patients With Lung Cancer. | He Y et al. | — | 2022 | → |
| Cuproptosis-associated genes and immune microenvironment characterization in breast cancer. | Shen L et al. | — | 2022 | → |
| Cyanobacterial Blooms Are Not a Result of Positive Selection by Freshwater Eutrophication. | Yu Y et al. | — | 2022 | → |
| Detection of m<sup>6</sup>A RNA modifications at single-nucleotide resolution using m<sup>6</sup>A-selective allyl chemical labeling and sequencing. | Peng Y et al. | — | 2022 | → |
| DeteX: A highly accurate software for detecting SNV and InDel in single and paired NGS data in cancer research. | Cui Y et al. | — | 2022 | → |
| Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies. | Ghobadi A et al. | — | 2022 | → |
| Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028). | Li M et al. | — | 2022 | → |
| Enhancer-associated regulatory network and gene signature based on transcriptome and methylation data to predict the survival of patients with lung adenocarcinoma. | Huang S et al. | — | 2022 | → |
| Enhancing diagnosis of T-cell lymphoma using non-recombined T-cell receptor sequences. | Chen YL et al. | — | 2022 | → |
| Epidemiologic and genomic investigations of an unusual increase in Salmonella enterica serovar Paratyphi A infection among travelers returning from Myanmar in 2015. | Matono T et al. | — | 2022 | → |
| Epithelioid glioblastoma exhibits a heterogeneous molecular feature: A targeted next-generation sequencing study. | Pan R et al. | — | 2022 | → |
| Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration. | Jiang XF et al. | — | 2022 | → |
| Frequent somatic mosaicism in T lymphocyte subsets in individuals with and without multiple sclerosis. | Van Horebeek L et al. | — | 2022 | → |
| From Samples to Germline and Somatic Sequence Variation: A Focus on Next-Generation Sequencing in Melanoma Research. | Muñoz-Barrera A et al. | — | 2022 | → |
| Fundamental and practical approaches for single-cell ATAC-seq analysis. | Shi P et al. | — | 2022 | → |
| FVC as an adaptive and accurate method for filtering variants from popular NGS analysis pipelines. | Ren Y et al. | — | 2022 | → |
| Genetic analysis of the ATP11B gene in Chinese Han population with cerebral small vessel disease. | Yu WK et al. | — | 2022 | → |
| Genetic Diversity and Geographical Distribution of the Red Tide Species <i>Coscinodiscus granii</i> Revealed Using a High-Resolution Molecular Marker. | Huang H et al. | — | 2022 | → |
| Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients. | Jia B et al. | — | 2022 | → |
| Genome analysis of Psilogramma increta granulovirus and its intrapopulation diversity. | Zhang H et al. | — | 2022 | → |
| Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma. | Tanaka N et al. | — | 2022 | → |
| Genomic features of Helicobacter pylori-naïve diffuse-type gastric cancer. | Namikawa K et al. | — | 2022 | → |
| Genopathomic profiling identifies signatures for immunotherapy response of lung adenocarcinoma via confounder-aware representation learning. | Deng J et al. | — | 2022 | → |
| High-throughput engineering of cytoplasmic- and nuclear-replicating large dsDNA viruses by CRISPR/Cas9. | López-Muñoz AD et al. | — | 2022 | → |
| Identification of differentially expressed genes at the single-cell level and prognosis prediction through bulk RNA sequencing data in breast cancer. | Chen H et al. | — | 2022 | → |
| <i>DNAH7</i> mutations benefit colorectal cancer patients receiving immune checkpoint inhibitors. | Yang W et al. | — | 2022 | → |
| Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants. | Del Vecchio C et al. | — | 2022 | → |
| <i>Naegleria</i> genus pangenome reveals new structural and functional insights into the versatility of these free-living amoebae. | Dereeper A et al. | — | 2022 | → |
| Inferring <i>bona fide</i> Differentially Expressed Genes and Their Variants Associated with Vitamin K Deficiency Using a Systems Genetics Approach. | Rajagopal S et al. | — | 2022 | → |
| Integrated investigation of the prognostic role of HLA LOH in advanced lung cancer patients with immunotherapy. | Zhang X et al. | — | 2022 | → |
| Investigating the <i>Leishmania donovani sacp</i> Gene and Its Role in Macrophage Infection and Survival in Mice. | Paulini K et al. | — | 2022 | → |
| Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling. | Wang T et al. | — | 2022 | → |
| Limited accumulation of high-frequency somatic mutations in a 1700-year-old Osmanthus fragrans tree. | Duan Y et al. | — | 2022 | → |
| Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors. | Golder A et al. | — | 2022 | → |
| NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. | Rosa-Rosa JM et al. | — | 2022 | → |
| Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes. | Wei W et al. | — | 2022 | → |
| Panel Sequencing of Primary Cutaneous B-Cell Lymphoma. | Wobser M et al. | — | 2022 | → |
| Preliminary study on the molecular features of mutation in multiple primary oral cancer by whole exome sequencing. | Li K et al. | — | 2022 | → |
| Protocol for <i>ex vivo</i> competition and sequencing of mycobacterium isolated from infected guinea pigs. | Naz S et al. | — | 2022 | → |
| Read Count Patterns and Detection of Cancerous Copy Number Alterations in Plasma Cell-Free DNA Whole Exome Sequencing Data for Advanced Non-Small Cell Lung Cancer. | Jang H et al. | — | 2022 | → |
| Recognition of Pep-13/25 MAMPs of <i>Phytophthora</i> localizes to an <i>RLK</i> locus in <i>Solanum microdontum</i>. | Lin X et al. | — | 2022 | → |
| Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells. | Kim T et al. | — | 2022 | → |
| Remembering St. Louis individual-structural violence and acute bacterial infections in a historical anatomical collection. | Austin RM et al. | — | 2022 | → |
| Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus. | Guo C et al. | — | 2022 | → |
| Somatic Mutational Landscape in Mexican Patients: <i>CDH1</i> Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma. | Cerrato-Izaguirre D et al. | — | 2022 | → |
| Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer. | Boström M et al. | — | 2022 | → |
| Somatic mutations during rapid clonal domestication of <i>Populus alba</i> var. <i>pyramidalis</i>. | Zheng Z et al. | — | 2022 | → |
| Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape. | Golkaram M et al. | — | 2022 | → |
| Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making. | Sun D et al. | — | 2022 | → |
| Tangent normalization for somatic copy-number inference in cancer genome analysis. | Gao GF et al. | — | 2022 | → |
| The A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50. | Gao C et al. | — | 2022 | → |
| The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Garsed DW et al. | — | 2022 | → |
| The Prediction of Necroptosis-Related lncRNAs in Prognosis and Anticancer Therapy of Colorectal Cancer. | Xiao H et al. | — | 2022 | → |
| The prevalence and prognosis of next-generation therapeutic targets in metastatic castration-resistant prostate cancer. | Pan J et al. | — | 2022 | → |
| The Somatic Mutation Landscape of UDP-Glycosyltransferase (<i>UGT</i>) Genes in Human Cancers. | Hu DG et al. | — | 2022 | → |
| Towards an accurate and robust analysis pipeline for somatic mutation calling. | Jin J et al. | — | 2022 | → |
| Transcriptome profiles of fatty acid metabolism-related genes and immune infiltrates identify hot tumors for immunotherapy in cutaneous melanoma. | Dong Y et al. | — | 2022 | → |
| Tuberculosis treatment failure associated with evolution of antibiotic resilience. | Liu Q et al. | — | 2022 | → |
| Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes. | Gonzalez-Bosquet J et al. | — | 2022 | → |
| Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma. | Wang J et al. | — | 2022 | → |
| XCVATR: detection and characterization of variant impact on the Embeddings of single -cell and bulk RNA-sequencing samples. | Harmanci A et al. | — | 2022 | → |